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 Neurocysticercosis (NCC) is the most common parasitic infection of the central 
nervous system (CNS) caused by the helminth parasite Taenia solium (T. solium) and 
affects 50-100 million people worldwide. Its clinical symptoms include headache, seizures, 
hydrocephalus, epilepsy and stroke. These clinical symptoms can have life-long 
detrimental effects.  As many as half of the total adult-onset seizures and 10% of the stroke 
cases in the endemic areas are attributed to NCC, whereas 20% to 30% of symptomatic 
patients display hydrocephalus. Treatment of NCC remains a major challenge as the 
severity of the symptoms is thought to be elicited by the degenerating larvae resulting from 
therapeutic treatment or normal attrition. Specifically, the inflammatory response in the 
CNS detected during symptomatic phase is thought to be responsible for the 
neuropathology and underlining cause of clinical symptoms. Interestingly, NCC has a long 
asymptomatic phase, typically lasting 3-5 years before the onset of the symptomatic phase. 
This asymptomatic phase is characterized by little or no signs of inflammation detected 
around the live cysts. Thus it is commonly believed that viable cysticerci induce immune 
suppressive effects, and loss of these effects when the parasite dies likely leads to activation 
of uncontrolled inflammatory response and neuropathology.  Therefore, treatments with 
anti- parasitic drugs combined immunosuppressive/ anti-inflammatory factors such as 
xi 
corticosteroids are predominantly used to control the host immune inflammatory response. 
However, their longtime use can cause other problematic side effect. The characterization 
of the immunoregulatory mechanisms in the CNS during helminth parasitic infection is 
critical to develop novel therapeutic targets for NCC, which can aid in finding treatment of 
a plethora of chronic neuro-inflammatory diseases as inflammation plays central role in 
development of majority of the chronic CNS inflammatory/autoimmune diseases.  
  
 The severity of the symptoms is associated with the intensity and chronicity of the 
local immune response in the CNS, use of a mouse model is essential to perform kinetic of 
analysis of the entire infection process. Because T. solium is not infectious to mice, use of 
Mesocestoides corti (M. corti), a relative cestode, has allowed for a more controlled study 
of the entire infection process, and to better characterize the immune response in the CNS 
microenvironment. Importantly, analysis of the infected CNS in the murine NCC model 
paralleled results obtained with brain specimens from NCC patients showing release of 
glycan antigens that are uptaken by host immune cells in the parasite infected CNS of 
humans and mice. In this regard, multiples researchers had indicated that glycans from 
pathogens, including helminths, act as pathogen-associated molecular pattern molecules 
(PAMPs), which are knowns to be recognized by C-type lectin receptors (CLRs) through 
their carbohydrate recognition domains (CRDs) and function as important pattern 
recognition receptors (PRRs). We, therefore, hypothesized that M. corti larvae in the CNS 
release their antigens glycoconjugates molecules which induce the expression of specific 
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lectin receptors (LRs) such as galectins. The LRs may play important role in regulating the 
immune response and pathology during NCC.  
  
 Parasites, particularly helminths, tend to shift the balance of immunity to a Th2 type 
of response, and it is likely that Th2 immunity evolved in response to infections with these 
parasites. The Th2 response activates or expands alternatively activated macrophages (M2 
macrophages) which are associated with suppressive activity. The development of M2 
macrophages is thought to be crucial in establishment of chronic parasitic infections as they 
express various negative signaling accessory molecules to downregulate the proliferation 
of activated T cells, and promote healing and tissue remodeling (1-3). In this regard, 
previous studies involving the mouse model of NCC showed the presence of macrophages 
with M2 phenotype in the CNS microenvironment. Moreover, a reduction in CNS levels 
of M2 macrophages in STAT6-/- mice undergoing NCC is correlated with widespread tissue 
damage and greater mortality (4). This is exciting as M2 macrophage mediated anti-
inflammatory/ neuro protective functions could be important in nervous tissue repair as 
well as containment of neuropathology in myriad neuro-inflammatory diseases.  However, 
the specific role of these M2 cells during NCC infection still remind to be determined.  
 
 The tegument in helminths such as T. solium and M. corti is dynamically responsive 
to changing host environments or immune attack in the CNS. During CNS infection of both 
these parasites, glycan antigens from the rapidly released in the CNS. Interestingly the 
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glycan antigens containing terminal galactose and galactosamine (detected by the lectin 
IB4) is rapidly released (1-2d p.i.), and it is almost absent after 1 wk of infection. This was 
correlated with differential upregulation of the Galectins (Galectin-3, -7, and -9), a family 
of the galactose specific LRs, in the CNS during murine NCC. The aim of the studies is to 
study the specific roles of galectin 3, galectin 7, and galectin 9, in regulation of immune 
functions in the CNS microenvironment during murine CNS infection. 
 Here we report that M2 macrophages in the parasite-infected brain display abundant 
galectin-3 expression. Disease severity was increased in Galectin 3-/- mice correlating with 
increased neurological defects, augmented cell death and, importantly, massive 
accumulation of neutrophils and M2 macrophages in the CNS of these mice. Because 
neutrophil clearance by efferocytosis is an important function of M2 macrophages, we 
investigated a possible role of galectin 3 in this process. Indeed, Galectin 3 deficient M2 
macrophages exhibited a defect in efferocytic clearance of neutrophils in-vitro. 
Furthermore, adoptive transfer of M2 macrophages from Galectin 3 sufficient WT mice 
reduced neutrophilia in the CNS and ameliorated disease severity in parasite-infected 
Galectin 3-/- mice. Together, these results demonstrate for the first time a novel role of 
galectin 3 in M2 macrophage function in neutrophil turnover and resolution of 
inflammatory pathology in the CNS. This likely will have implications in 
neurocysticercosis and neuroinflammatory diseases. 
  Analysis of helminth-infected mice revealed an abundant expression of Galectin 7 
(Gal 7) that recognize galactose moieties in brain endothelial cells. The Galectin 7-/- NCC 
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mice displayed a reduced accumulation of M2 macrophages in the parasite-infected brain. 
This reduction in M2 macrophage numbers in the CNS was correlated with an increased 
neuropathology and shortened survival. The use of adoptive transfer of fluorescently 
labeled cells demonstrated a decreased influx of M2 macophage into the CNS of helminth-
infected NCC brains. The use of in-vitro transmigration assay conclusively demonstrated 
a key function of Galectin 7 expressed on endothelial cells in centrally regulating M2 
macrophage entry into the CNS. The results are highly significant as the BBB restricts the 
flow of both cells into the brain, and the fact that galectin-7 regulates M2 macrophage 
extravasation into the CNS could be of great importance how to contain neuropathology in 
CNS infection.  
 Galectin 9 was the first to be upregulated as well as at a relatively high level in M2 
macrophage. Parasite-infected Galectin 9-/- mice displayed significantly increased 
susceptibility to parasite infection, despite a similar parasite burden in the CNS compared 
to infected WT mice. The accumulation of macrophages, γδ T cells, αβ T cells, or B cells 
in the brains of parasite-infected Galectin 9-/- mice was similar to the WT mice. Moreover, 
AAMs which play a profound protective role in murine NCC were observed an increased 
level in infected WT and Galectin 9-/- mice. Instead, the parasite-infected Galectin 9-/- mice 
exhibited a massive neutrophilia in the CNS and an increase in neutrophil-associated 
neuroinflammation. These results suggest that galectin 9 may be involved in controlling 
and resolving neutrophilia and inflammation, however, not by efferocytosis. For the first, 
we showed in the possible correlation between the presence of Galectin 9 and neutrophilia 
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in NCC infection. Further experiments need to be done to determine the specific 
mechanism by which Galectin 9 is involved in this process. 
 In toto, our studies make an important contribution in establishing the novel 
protective mechanisms of M2 macrophages functions in the CNS pathological conditions. 
Our studies provide a better understanding of the immunopathogenesis of NCC which 







Neurocysticercosis: Clinical Symptoms, Epidemiology, and Burden to Society 
 Neurocysticercosis (NCC), is the most common parasitic infection of the Central 
Nervous System (CNS) caused by the larvae stage metacestode of the zoonotic tapeworm 
Taenia solium (9-11). The most frequent clinical manifestation associated with NCC are 
seizures, hydrocephalus, strokes, and symptoms associated with increased intracranial 
pressure (12, 13). Particularly, strokes, seizures and late-onset epilepsy associated with 
NCC have devastating effects on the well-being of infected people and socio-economic 
development in affected communities (12). NCC accounts for 70-90% to seizures cases 
and 4%-12% of the total stroke case in endemic areas (12, 14, 15) 
 NCC is considered as a major public health problem because it contributes to more 
than 50,000 deaths worldwide every year (12, 14-17). The incidence of NCC is most 
common in developing countries of Asia, Africa, and Latin America, where this disease is 
considered to be endemic (17). NCC used to be rare in developed countries. However, the 
recent increase of travel to endemic areas as well as immigration from endemic places 
likely have contributed to the ever increasing incidences of NCC reported in developed 
countries (18, 19). In the United States, NCC is mostly found to be prevalent in a Hispanic 
population. More than 1000 new cases are diagnosed every year in the Southwest region 
 
2 
of the USA, where NCC account for more than 2% of neurological admission. 
Life Cycle of Taenia Solium 
 The life cycle of T. solium is complex, which involves a larval stage (metacestode) 
and an intermediate host (pig) and human as the only known definitive host (Figure. I-1) 
(17-20). NCC is transmitted to humans through ingestion of contaminated food, mainly by 
eating raw/under-cooked larvae infected pork meat. Upon ingestion, metacestode reaches 
the small intestine and attach to the intestinal wall. The adult worm develops in the small 
intestine by forming segments called gravid proglottids. The eggs in these proglottids are 
self-fertilized and released into the environment, where they can survive for many months 
before entering another host. Pigs ingest T. solium eggs contaminated food or water in 
endemic areas. Once the eggs reached the intestine of the pigs, they transformed to an 
invasive form called oncospheres. Oncospheres can cross the intestinal wall and reach 
different tissues of the host through the body fluid. In the tissues, they transform into 
cysticerci in a period of 3 weeks to 2 months (12, 14, 16, 17). The infection cycle continues 
when the humans eat undercooked pork infected with T. solium. 
 In human’s small intestine, embryo releases the oncospheres due to the action of 
gastric juices. The oncospheres hatch and cross the intestinal mucosa. They can migrate 
and established in muscles, subcutaneous connective tissues, CNS, eyes, liver and other 
organs, where they mature into cysticerci and cause pathogenesis. To migrate to striated 
muscles, liver, and other tissues, where they develop into cysticerci. In humans, when the 
parasite lodges in the CNS, the cysts can cause serious illness resulting in 





Figure I- 1.  The life cycle of Taenia solium. 
Neurocysticercosis is the result of the ingestion Taenia solium’s cyst. Human becomes 
infected either by ingesting contaminated food or autoinfection. In the cause of 
autoinfection, cysts are passed to the environment by an infected human and re-enter the 
infected body where they migrate to the central nervous system (CNS). Once in the brain, 
the eggs differentiate into oncosphere which matures into cysticerci which into 
neurocysticercosis. In the other hand, eggs can also contaminate vegetation in the 
environment where they last for months until, a pig which is the intermediate host, feed 
into it and become infected. Inside the animal, eggs migrate into the intestinal wall where 
they differentiate into oncosphere and migrate the muscle where they mature into 
cysticerci. Human becomes infected by eating contaminated meat where the cysticerci 
migrate to the brain and induce neurocysticercosis.  
 
4 
 Type of Neurocysticercosis 
  Inactive Neurocysticercosis: Inactive NCC represents the cases in which 
only cysts or only trace residues of the cysts are visible by neuroimaging studies. 
Parenchymal calcifications are the most common form of inactive NCC. Some patients 
with inactive NCC reveal the presence of hydrocephalus (14).  
  Active intra-parenchymal Neurocysticercosis: Intra-parenchymal is the 
most common form of the disease, which involves the parenchyma of the cerebral 
hemispheres. Presence of lesion in the parenchyma commonly detected, particularly at the 
gray matter-white matter junction. Intraparenchymal NCC patients present seizures in most 
patients as well as headaches and hypertension (12, 20). Many patients with 
intraparenchymal NCC may resolve the infection in few years (12, 20). Whereas many 
others develop cysticercal encephalitis, another form of intra-parenchymal NCC present in 
young adolescents. Untreated patients are more likely to develop severe neurological 
disorders  
  Extra-parenchymal neurocysticercosis  
  Ventricular neurocysticercosis: About 10 to 20% of symptomatic patients 
will develop this type of NCC. The cysts are predominantly found in the ventricles and 
associated with the obstruction of the cerebrospinal fluid (CSF) flow (12, 20). Whereas 
minor percentage of patients with subarachnoid cysticerci display meningeal signs due to 
the presence of cyst(s) in the subarachnoid spaces (12, 20). 
Pathogenesis of NCC  
 The intensity of the immune response is thought to play the most significant role in 
the pathogenesis of NCC. The disease severity also is depended on other factors, including 
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the number of parasites, the stage of the parasite, size, location in the CNS, and duration 
of infection (21). 
 Duration of infections:  
 Duration of parasite infection of the CNS is a critical determinant of NCC severity 
and disease outcome. The infection process in the CNS of NCC patient can be broadly 
defined in three different phases. In the first phase of infection, the parasite thought to enter 
the CNS and establish itself by evading the host immune responses. However, direct 
evidence regarding the initial clinical symptoms and immune responses in the CNS 
microenvironment is minimal. The second phase is the asymptomatic phase typically 
lasting from 3 to 5 years after infection of the CNS. During the asymptomatic phase, the 
host does not display any clinical symptoms thought to be due to viable cysticerci induce 
immune suppressive effects. This phase is characterized by little or no signs of 
inflammation detected around the live cysts (5, 7, 8, 14, 17). Because of technical 
limitations involved, the immunopathogenesis of asymptomatic phase is primarily 
established by analyzing the nervous tissue of patients who have died due to other co-
morbidities other than the disease itself. The third phase is the symptomatic phase in which 
the parasite degenerates and releases parasitic molecules into the surrounding tissue 
causing a wide range of clinical symptoms caused by the resulting inflammatory responses 
of the host (14). Indeed, it is commonly believed that the viable cysticerci induce immune 
suppressive effects and loss of these effects when the parasite dies likely leads to activation 




Stage of the Cysts  
 Previous studies using magnetic resonance imaging (MRI) and computed axial 
tomography (CT) had shown parasites go through different stages after entering the CNS 
(12, 14, 22). The first state is the vesicular stage, where the live parasites induce immune 
suppressive/ regulatory effects with little to none inflammatory response detected in the 
CNS microenvironment (18, 20). The second stage is the colloidal cysticerci, where there 
is a presence of gelatinous material in the cyst fluid. During this stage, the parasite is in the 
dying process and surrounded by a thick collagen capsule (21-24). The third stage is the 
granular nodular stage in which the cyst starts to contract, and the walls are transformed 
into coarse mineralized granules followed by necrosis (21-24). The last stage is the nodular 
calcified stage when the cyst has died and collagenous structures are formed by 
calcification of the cyst (21-24). 
Immune response in patient undergoing NCC due to helminth infection of the CNS 
General and immunological features to helminth infections 
 Helminths parasites are multicellular eukaryotes that often cause acute and chronic 
pathologies. The mechanisms of host defense that control microbial infections are broadly 
divided into two categories, innate and adaptive immune responses. Innate immune 
responses represent the first line of host defense and constitute a multifaceted and rapid 
response to pathogens. It is induced by the interaction of pattern recognition receptors 
(PRRs) on host cells with conserved pathogen-associated molecular patterns (PAMPs) 
(25). Such interactions result in the development of host Th1 type inflammatory responses 
that play an important role in the elimination of the organism (25, 26). However, helminth 
parasites have evolved to co-exist in the host and induce compensatory responses often 
 
7 
leading to the inability of the host to eliminate the parasite (25-27). Parasites, particularly 
helminths, tend to shift the balance of immunity to a Th2 type of response. 
Immunological features in patients with neurocysticercosis:  
 In humans for a long period of time after the infection of the CNS, the host remain 
asymptomatic. The direct evidence on the kinetic of host-pathogen interaction in the CNS 
microenvironment involved in the sequential progression from asymptomatic to 
symptomatic stage remains to be clearly understood. However, correlative studies strongly 
suggest that the asymptomatic stage is associated with the presence of the live parasites in 
the CNS. As the absence of clinical symptoms in infected people coincides with a lack of 
detectable inflammatory response in the CNS, it has been assumed that the viable cysticerci 
induce immune suppressive effects to evade the immune response (4, 28). A number of 
immunomodulatory mechanisms the live parasites use to invade the host immune system 
include suppressing lymphocyte activation (27, 29). T. solium inhibits both the classical 
and alternative pathways of complement activation by the release of the molecules 
paramyosin (binds to C1q) and taeniaestatin (30, 31). Lymphocyte proliferation and 
inflammatory cytokine production are mitigated ex vivo (32). During this asymptomatic 
phase of infection, even the PBMCs stimulated with T. solium antigens produce T helper 
(Th2) 2 cytokines such as IL-4, IL-5, and IL-13 (33), suggesting an anti-inflammatory 
response prevails during the symptomatic phase. These live parasite-mediated immune 
suppressive/ anti-inflammatory mechanisms could be critical for parasite survival and to 
co-evolve with the host to establish chronic infections. In contrast, the analysis of CNS 
tissue specimens from NCC patients reveals that the immune response consists of an overt 
Th1 phenotype (32) or a mixed Th1, Th2, and Th3 phenotype depending upon the absence 
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or presence of granuloma formation (10, 23). Moreover, the Th1 cytokines are detected in 
higher concentration in the cerebral spinal fluid (CSF) of symptomatic NCC patients vs. 
asymptomatic patients (32). Although direct evidence that the Th1 inflammatory response 
contributes to the neuropathology is limited, treatment of NCC patients with corticosteroids 
help to control Th1-inflammatory response along-with neuropathology and disease 
severity (10, 32). However, the appropriate immune responses that are required to control 
the infection or the CNS inflammatory pathology in human patient are largely unknown. 
In this regard, the majority of studies in NCC are focused on T-cell mediated immune 
responses, possibly due to the presumed role of Th1 cells on the immunopathogenesis. 
Nevertheless, macrophages around the metacestode in the CNS of humans with 
symptomatic NCC display a low expression of MHC-II molecules, although it appears to 
be higher in cells located further away from the parasite (34). Indeed, Downregulation of 
MHC-II in macrophages by regulatory T cells (Tregs) and Th2 cells have been shown to 
play an important role in establishing chronic helminth infections with limited 
inflammatory pathology in their hosts (27). Owing to the critical roles of macrophages and 
microglia in both innate immune and adaptive immune effector pathways in the CNS, 
identifying their phenotypes and their associated functions in NCC is essential for 
understanding the disease process.  
Murine Model of NCC 
 Examining brain specimens from patients that have undergone emergency 
craniotomies, have been critical to characterize the immune response in the CNS 
microenvironment in NCC and the associated pathology. As the severity of the symptoms 
is associated with the intensity and chronicity of the local immune response, use of a mouse 
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model is essential in order to allow for a kinetic analysis of the infection process in the 
CNS with a more controlled experimental setup. Attempts to develop animal models using 
T. solium to mimic host-pathogen interaction have failed in several laboratories as it does 
not infect the CNS naturally. Other Taenias such as T. crassiceps do not infect the CNS of 
mice through the fecal-oral route as occurs naturally during T. solium infection in human. 
Attempts to develop a CNS infection by intra-cranial injection of these parasites failed in 
many laboratories as the metacestodes displaced most of the nervous tissue due to their 
large size. Although T. solium infects the CNS naturally in pigs, the approach is not cost 
effective. Moreover, it is difficult to do a mechanistic study in infected pigs in laboratories 
setting to understand the kinetics of immunopathological events in the CNS during the 
entire course of infection (35). Many other laboratories had used the artificial infection 
caused by Taenia crassiceps cysticerci which is injected into the abdominal cavity of mice. 
This model has been useful to understand the impact of immune, sexual and endocrine 
factors on the disease, and to study the efficacy of anti-parasitic drugs for cysticercosis. 
However, it does not allow to study NCC (35, 36) as the intraperitoneal environment barely 
resemble human CNS condition (35).  
 We and Judy Teale’s laboratory at the UTHSCSA/ UTSA have been using another 
closely related cestode, Mecestoides corti (M. corti), with a known life cycle similar to T. 
solium, to study the kinetic analysis of the events in CNS microenvironment in nice. The 
life-cycle of M. corti involves two hosts. The parasite is believed to ingested by terrestrial 
arthropods. An intermediate host such as mouse and lizard consume arthropod carrying M. 
corti (37, 38). Once inside the animal, the oncosphere develops into mature larvae. A 
definitive host such as dog, cat or skunk, consume the larvae, intermediate host. The larvae 
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develop into mature tapeworm releasing eggs in the definitive host for the life-cycle to 
continue (38). Owing to these remarkable similarities in life cycles of both M. corti and T. 
solium, murine model of NCC was developed by injecting M. corti intracranially. In 
laboratory, M. corti metacestodes are maintained by serial intraperitoneal inoculations of 
mice. Murine NCC is developed by injecting M. corti metacestodes i.c. in 3-5 wk old mice 
at the junction of the superior sagittal and the transverse sutures to avoid penetration of the 
brain tissue. During the first 24 hrs of infection, most of the metacestodes are found in the 
leptomeningeal space. Depending upon the duration of the infection and the type of host 
responses elicited, the distribution of M. corti metacestodes parallels that of T. solium as 
the parasite localizes in the subarachnoid space, ventricular areas and parenchyma (9, 38). 
In murine NCC, the first cells to infiltrate the brain are large numbers of macrophages, and 
T cells followed to a lesser extent by neutrophils, T cells and B cells. However, as observed 
in symptomatic NCC patients, the cytokine response of infiltrating cells in the CNS during 
M. corti infection is a mixed Th type response with higher IL-2, IL-12, IL-15, IFN-γ, and 
TNF-α indicative of a Th1 type of response (4, 9, 32, 39, 40), along with IL-4, IL-13 and 
IL-10 (Th2 type) detected in the CNS albeit at a relatively lower amount. Most importantly, 
similar to human NCC, the degree of inflammation in the CNS increases correlates with 
disease severity (4, 9, 32, 39, 40). Thus, murine NCC provides an important model for 
understanding the human disease which should aid in understanding the kinetics of the 
immunopathological events in the CNS microenvironment and the development of new 
therapeutic strategies. 
 Similar to human NCC, the degree of inflammation in the CNS correlates with the 
disease severity in murine NCC (10, 41). In these mice infected i.c. with M. corti, the Th1 
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cytokine response in the CNS microenvironment is mounted by γδ T cells (10, 42, 43). Use 
of γδ T-/- mice revealed that the inflammatory response by them contribute to infiltration 
of immune cells into the brain (30, 39) and enhance neuropathology and disease severity 
(10, 30). Thus, in the chronic stage of both human and murine neurocysticercosis, 
manifestation of the TH1 inflammatory response is the main cause of disease severity and 
mortality. Importantly, the murine NCC provides an important model for understanding 
the human disease which should aid in understanding the kinetics of the 
immunopathological events in the CNS microenvironment and the development of new 
therapeutic strategies. 
Protective versus detrimental correlates in murine NCC 
 The last decade of research has demonstrated that Toll-like receptors of the innate 
immune system play an important role in eliciting host inflammatory responses (44, 45). 
In murine NCC, all the TLRs (TLRs1-13), except TLR5 are upregulated and differentially 
expressed among the various nervous tissue and infiltrating immune system cell types (46). 
Moreover, in the absence of MyD88, a central adaptor molecule associated with the 
signaling pathway induced by all the TLRs activation except for TLR3, infiltration of 
immune cells into the CNS was reduced. MyD88-deficient mice infected with M. corti, 
display an enhanced ability to survive the infection as compared to wild-type mice, 
correlated with a decreased Th1 inflammatory cytokine responses along with reduced 
neuropathology. Thus, inflammatory responses mediated by immune modules such as by 
TLR system and γδ T cells, play detrimental roles during murine NCC. In contrast, despite 
a reduced inflammatory response characterized by a decreased Th1 inflammatory 
responses observed in the CNS of TLR2-/- NCC mice, these mice displayed a higher 
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neuropathology correlated with an increased mortality. Interestingly, TLR2-/- NCC mice 
exhibited decreased numbers of M2 macrophages in the CNS, suggesting that maybe M2-
macrophages play an important protective role in mice i.c. infected with M. corti. Indeed, 
after M. corti i.c. infection mice deficient in STAT6, which is a central regulator of M2 
macrophage development and function (4), display a greater neuropathology and mortality 
correlated with a scarce presence of M2 macrophages in the CNS. Thus, the M2 
macrophages mediated protective mediators could be important for controlling the 
neuropathology and overall disease severity in murine NCC.  
Macrophages functional phenotypes in infections and injury 
 Macrophages are key effectors cells of the immune system (47). Macrophage 
plasticity is essential for innate immunity and tissue remodeling (47-49). The functional 
phenotypes of macrophage vary in response to external stimuli they receive through a wide 
variety of surface receptors (50). Macrophage with the M1, or classical activation 
phenotype, release multiple pro-inflammatory molecules (51). M1 or classically activated 
macrophages are activated by environmental signals such as IFN-γ or TLR ligands. IFN-γ 
binds to IFNGR-1 and IFNGR-2 chains which form INFGR-1 and recruit JAK1 and JAK2 
adaptors proteins. Ultimately the activation of the signal transduction pathways involving 
phosphorylation of STAT1, IRF-1, and IRF-8, ultimately orchestrate the transcription of 
pro-inflammatory molecules (47). M1- macrophage activation associated production of 
inflammatory molecules, including the production of NOS2, IL6 and TNF-α, play critical 
role in protection from microbial pathogenic infection (47). In contrast, M2 macrophages 
or alternatively activated macrophages are involved in anti-inflammatory and tissue 
protective response (1, 49, 52-54). M2 macrophage activation results from exposure to 
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environmental cues such as cytokines IL-4 or IL-13 (M2a subtype), agonists of IL-1 
receptor and TLR (M2b subtype), IL-10 and glucocorticoid hormones (M2c subtype), or 
activation of adenosine A2A receptors (M2d subtype) (17). The M2a macrophages are 
involved in allergies responses induced by th2 responses and killing of parasites (1, 47). 
The M2b phenotypes are involved in Th2 cells differentiation and humoral antibody 
production. The M2c macrophages play a role in immune regulation and tissues repair (1, 
47). Whereas M2d macrophages believed to play a role in protecting from tissue injury (1). 
Thus, M2 macrophages are involved in many physiologic and pathological processes such 
as homeostasis, inflammation, metabolic function, allergy, and parasites infection. 
M2 Macrophages Functions in Wood Healing  
 Wood macrophages are referred IL-4 induced macrophages due to the several 
tissues remodeling molecules produced by these macrophages including Arginase, and 
YM-1 (48). Arginase-1 an enzyme is a prototypic marker of AAM in mice. For a long time, 
Arginase-1 was believed to be the primary wound healing protein and it is induced 
transcriptionally by TGF-β, IL-4, and IL-13 proteins. Arginase-1 uses the amino acid L-
arginine as substrate and break it down into L-ornithine and urea. L- Ornithine is believed 
to be involved in collagen biosynthesis which ultimately promotes fibrosis and tissue 
healing (55). YM-1 is a lectin with affinity to glycosaminoglycans like heparin. YM-1 is 
considered as M2 marker in a mouse model and it is upregulated by IL4 and IL-13 and its 
expression may be directly correlated IL-10 production. This protein has been associated 
with cellular recruitment and extracellular matrix deposition during tissue repair. 
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M2 Macrophages Functions in Helminth Infections  
Immune response involving M2 macrophages are hallmarks of chronic type 2 pathological 
conditions, including in helminth parasitic infection (3, 56). Specifically, M2 macrophages 
have been suggested to involve in the expulsion of certain helminths (57). In this regard, 
M2 associated molecule YM-1, a chitinase, play an important role in cleaving the surface 
chitin on helminth parasites thereby making their plasma membrane accessible to host 
mediators. Importantly, M2 macrophages functions in wound healing (4, 43, 47, 58) 
thought to be crucial to repair tissues damages caused by the parasites or due to 
inflammation (47, 57). 
 As mentioned before, M. corti infection of the CNS of mice resulted in massive 
accumulation of M2 macrophages, correlated with a complete lack of any iNOS+ M1 
macrophages (4, 43). As STAT6-/- mice infected with M. corti displayed a decreased 
number of M2 macrophages correlated with severe disease sign (4), an understanding of 
the molecular mechanisms associated with the development, recruitment, and/ or functions 
of M2 macrophages in murine NCC could be important for understanding how NCC can 
be clinically controlled.  
Glycan antigens in host-parasite immune responses during NCC 
More than 95% of NCC patients exhibit humoral responses against glycan antigens (13, 
24). Glycan antigens are released both in humans and mice NCC (9, 29) and are taken up 
by infiltrating immune cells around the metacestodes (9), suggesting their role in 
immunopathogenesis. It is commonly believed that in order establish a long-lasting 
infection in the host, parasites helminths release glycans present on their surface or through 
excretory /secretory products (59, 60). These helminth parasite-derived glycans are 
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grouped into two distinct sets: the host like and non-host like glycans (59). Various types 
of host-like glycans are found in different parasites (61-63). The terminal glycan structures 
shared by bost host parasites include LeX, LDN, and LDNF as well as the truncated-
glycans known as the T (Galβ-3GaNAcα-O-Thr/Ser) and Tn (GalNAcα-O-Thr/Ser) 
antigens (61-63). Remarkably, the host-like glycans can also induce the production of anti-
glycan responses resulting from the “foreign” presentation of the host-like glycan antigens 
in highly multivalent forms as well as their linkage to immunogenic helminth proteins. 
Interestingly, the synthesis of the non-host-like glycan moieties in the helminths appears 
to be strongly upregulated during infection of the mammalian host (59, 64). In contrast, 
non-host-like glycans contain unusual molecules including polyfucose, tyvelose, terminal 
GalNAc, phosphorylcholine, methyl groups, and sugars with unusual linkages (59). As can 
be expected, these non-host-like glycans are highly immunogenic in nature and induce the 
generation of dominant anti-glycan antibody responses in infected hosts (62). Interestingly, 
the synthesis of the nonhost-like glycan moieties in the helminths appears to be strongly 
upregulated during infection of the mammalian host (64) suggesting a biological relevance 
for their expression. 
 NCC patients exhibit humoral responses against N-glycan antigens, presumably 
released from the parasite in the CNS. Indeed, carbohydrate-based antigens are extensively 
used for immunodiagnosis of this disease. These glycan antigens are mostly expressed in 
the parasite’s tegument (external surface) that remains in contact with the host as well as 
secreted molecules. Both in human and mouse NCC, the glycans in tegument of T. solium 
and M. corti are released into the CNS microenvironment (9). In murine NCC, the glycan 
antigens containing terminal galactose and galactosamine is rapidly released (1-2d p.i.), 
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whereas glycan antigens containing terminal glucosamines are constantly released during 
the CNS parasitic infection. We speculate that interaction of some of these parasite glycan 
antigens with PRRs e.g. lectin receptors dictate the immune regulatory mechanisms 
involved in NCC (9, 41).  
Lectin Receptors, Galectins: Structure, and Functions 
 PRRs (Patterns recognizing Receptors) are accountable to detect the presence 
pathogens by recognizing their PAMPs (Pathogen Associated Molecule patterns) (25). 
PRRs are expressed by host cells mostly by APC (antigen presenting Cells) which include 
macrophages and dendritic cells but also by non-phagocytic cells. PRRs include the Toll-
Like Receptors (TLRs), (RIG) - like receptors, the NOD-like receptors and the Lectin 
receptors (LRs) (65, 66). 
Lectin Receptors 
 Lectin receptors (LR) are carbohydrates binding proteins found in most animals 
and plants (66, 67). Within multicellular organisms, protein–carbohydrate recognition is 
critical to intracellular processes, such as protein folding and transport (66, 67). Such 
interactions play various important homeostatic and protective functions in the hosts such 
as extracellular matrix in its function including cell differentiation, adhesion, and 
migration, and embryogenesis. Moreover, host lectins can also act like PRRs to sense 
pathogen released molecules (66). Thus, LRs represent a family of multifunctional host 
molecules that are involved in fine-tuning the host immune system in a variety of 
conditions. Owing to such flexibility of these LRs in modulating a variety of immune 
functions, it is necessary to study these and similar molecules in a microenvironment 
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specific manner. However, the role of targeted LRs in the regulation of immune functions 
during CNS helminth infection is limited, if any. 
 Galectins: Galectins are β- galactoside binding proteins which share the same 
carbohydrate recognition domain (CRD) (68, 69). Based on their structural features, 
mammalian Galectins had been classified into three different groups (26, 70). The proto- 
types galectins have one CRD per subunit and most of the time are associate as non-
covalently bound homodimers through a hydrophobic interphase (26, 70). This group 
includes galectins 1, 2, 5, 7, 10, 11,12,13,14, and 15. The chimera-type galectins have C- 
terminal a CRD similar to the proto-type. In addition, they possess an N-terminal amino-
terminal peptide that is rich in glycine, tyrosine, and proline which is involved in the 
formation of oligomers. The only member of that group is galectin 3. The last group is the 
tandem repeat (TR) galectins. They have two CRDs joined by a linker peptide. The 
members of this group include galectins 4, 6, 8, 9, and 12 (26, 70, 71).  
 Most galectins are non-glycosylated soluble proteins and are ubiquitously 
expressed and distributed in mammalian tissues, including innate cells such as dendritic 
cells, macrophages, mast cells, natural killer cells, γδ T cells, B1 cells and adaptive cells 
such as activated B and T cells of the immune system (26, 70). Although they lack signal 
sequence, they can be found in the extracellular, intracellular or nuclear milieu where they 
perform different functions which include cell migration, cell and protein interaction, and 
immune response regulation (26, 70). Their different functions are accomplished either by 
protein-protein interactions of protein-glycan interaction (69). Galectins have increase 
affinity to soluble extracellular matrix (ECM) glycoproteins such as fibronectins, lamins, 
and vitronectin (26, 68-75). For instance, Lysosome-associated membrane glycoprotein 1 
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(LAMP-1) is recognized by both galectin 3 and 1 (69). Moreover, galectin 3 binds to CD98 
on macrophages and CD66 on neutrophils. Galectin 9 on the other hand has been known 
to interact with Tim 3 and CD44 on activated T cells (26, 69, 76, 77). These galectins – 
glycoproteins complexes can interact with other ECM proteins and lead to their regulation 
effects and signaling cascades (26, 69, 76, 77). In addition, galectins also bind to 
membrane-bound proteins. Their interactions modulate the immune responses and 
inflammation (26, 69, 76, 77). Even though the role of galectins has been intensively 
studied in tumors cells, recently, an increased attention has been given to explore their roles 
during chronic infections. 
Galectin 3, Immune Response, and the CNS: galectin 3 is unique in chimera group 
and has been extensively studied for the past few years. It may have pro-inflammatory or 
anti-inflammatory function depending on the pathogens as wells as it microenvironment. 
Studies had shown galectin 3 intervenes in multiples cellular processes in vitro. It has been 
shown to play a role in DC-T cells interaction as well as cell- matrix glycoprotein adhesion. 
Galectin 3 exerts chemotactic effects, control cells proliferation (78). Furthermore, 
extracellular galectin 3 promotes neutrophil functions such as survival, phagocytosis, and 
extravasation (78, 79). 
  The role of galectin 3 during inflammatory conditions in the CNS had been 
investigated. Even though galectin 3 is expressed at a low level by some brain cells 
including neurons astrocytes and microglia, its expression is increased during some CNS 
infection. Galectin 3 was considered as a pro-inflammatory molecule during murine EAE. 
Despite its involvement in the phagocytosis of myelin debris in CNS which is advantageous 
for neural regeneration, galectin 3 is also known to be involved in the aggravation of the 
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of EAE because it plays a critical role in preventing apoptosis, reduce the production of 
IL-10 and increase IL-17’s level (6). In addition, galectin 3 was proving to play a role in 
mediating injury-induced microglia activation and proliferation in response to Ischemic 
injury (80).  
Galectin 3 and Helminth Infections: Galectin 3 expressed by DCs has been shown 
to modulate immune and inflammatory response by controlling the magnitude of T-
lymphocyte priming during helminthic infection (78). In addition, galectin 3 was found to 
be indispensable for the recognition and endocytosis of yeasts and is essential for TLR2-
dependent cytokine production in response to C. albicans (81). However, its role 
modulating innate responses during NCC is yet to be determined.  
 Galectin 3 and phagocytosis and efferocytosis. Studies had explored the role played 
by galectin 3 during both phagocytosis and efferocytosis. Galectin 3 expressed on 
macrophages was found to be critical in their phagocytosis function (5, 6). However, a 
recent study had suggested that galectin 3 expressed on neutrophil may help with their 
clearance during acute infection (82). Moreover, galectin 3 has been proven to not only 
enhance alveolar Macrophages' differentiation into AAMs phenotypes, it also enhances the 
clearance of apoptotic cells, therefore improves COPD (65). This suggested that galectin 3 
may play a role in the function of AAMs during NCC infection.  
Galectin 7 and Immune Response: Most of the studies done on galectin 7 had been in 
cancers tumors. Galectin 7 is normally expressed by keratinocytes and restricted to 
stratified epithelia, nevertheless, its expression is considerably altered in tumors cells (83). 
It had been reported to up-regulate the growth and propagation of lymphoma cells in vivo 
(84) as well as helping to eliminate tumors cells with it pro-apoptotic function (84). It 
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typically non-cancerous infections, galectin 7 expression on epithelial cells was found to 
be associated with pro-apoptotic functions as well as cell-cell adhesion (26, 70, 85). 
However, the role of galectin 7 during helminth infections is yet to be determined.  
Galectin 9 and Immune Response: Galectin 9 is another member of the galectins 
family which has an increase of interest and it’s from the tandem repeat group. Studies had 
shown galectin 9-Tim-3 interaction pathway induces antibacterial activity in human 
macrophages which were infected with Mycobacterium tuberculosis (8). In addition, 
galectin 9 was shown to be highly expressed by iTreg cells and its interaction with its 
receptor CD44 increase iTregs cells stability and their functions (86). However, the specific 
role of galectin 9 in the innate immune response during parasitic infection, particularly 
NCC is yet to be determined.  
Central Hypothesis 
It has been assumed that viable cysticerci induce immune suppressive effects to evade the 
immune response. Whereas after the degeneration of larvae caused by either therapeutic 
treatment or normal attrition, the loss of parasite-mediated immune modulatory effects 
leads to uncontrolled hyper-inflammatory responses contributing to tissue pathology. In 
this regard, a considerable body of evidence indicates that the host inflammatory responses 
elicited in the CNS contributes to nervous tissue pathology and is responsible for most of 
the clinical symptoms observed with NCC patients. Thus, anti-inflammatory treatments 
with corticosteroids are often prescribed along with anti-parasitic drugs to kill the organism 
and control the host inflammatory response and neuropathology. However, long-term 
treatments with steroids lead to life-threatening side effects. Therefore, it is important to 
identify the pathophysiological basis of the inflammatory as well regulatory responses 
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elicited in parasite-infected brains to aid in developing safer therapeutic strategies. 
Although, we previously contributed in identifying the role of TLR signaling pathway in 
regulating CNS inflammatory response and pathology, but the presence of the myeloid 
cells with M2 activation phenotype seemed to be necessary for containment of tissue 
pathology and disease severity. In this regard, one of the most important similarities 
between human and murine NCC is the documented release of parasite glycans in the CNS 
microenvironment. In addition, the terminal galactose-containing glycan are first to be 
released from the parasite and to larger extent, which coincides with the presence of large 
numbers of myeloid cells with M2 activation phenotype in the parasite-infected CNS. 
Thus, our goal was to study the role of lectin receptors in regulating M2 cell functions in 
the parasite-infected CNS. We hypothesize that the differential expression of galectins that 
recognize galactose moieties, in endothelial cells play a critical role in immunopathology 
by modulating trafficking of M2 macrophages into the CNS, whereas galectins expressed 
in M2 cells controls the protective functions of these cell types.  
 
1. Characterization of the differential expression and distribution of galectins in 
endothelial cells and M2 cells during murine NCC.  
2. Determine the function of galectin/s expressed in M2 cells, in regulating their 








   
 
 
Figure I- 2.  Galectins are upregulated during NCC. 
 WT mice were intracranially infected with M. corti. At 2 weeks post infected, brains 
were isolated and galectins mRNA were measured. Galectins were found to be up 
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 Macrophages/ microglia with M2- activation phenotype are thought to play an 
important anti-inflammatory and tissue reparative functions in the brain, yet the molecular 
basis of their functions in the central nervous system (CNS) remain to be clearly defined. 
In a preclinical model of neurocysticercosis using brain infection with a parasite 
Mesocestoides corti, we previously reported the presence of large numbers of M2 cells in 
the CNS. Here we report that M2 macrophages in the parasite-infected brain display 
abundant galectin-3 expression. Disease severity was increased in Galectin 3-/- mice 
correlating with increased neurological defects, augmented cell death and, importantly, 
massive accumulation of neutrophils and M2 macrophages in the CNS of these mice. 
Because neutrophil clearance by efferocytosis is an important function of M2 
macrophages, we investigated a possible role of galectin 3 in this process. Indeed, Galectin 
3 deficient M2 macrophages exhibited a defect in efferocytic clearance of neutrophils in-
vitro. Furthermore, adoptive transfer of M2 macrophages from Galectin 3 sufficient WT 
mice reduced neutrophilia in the CNS and ameliorated disease severity in parasite-infected 
Galectin 3-/- mice. Together, these results demonstrate for the first time a novel role of 
galectin 3 in M2 macrophage function in neutrophil turnover and resolution of 
inflammatory pathology in the CNS. This likely will have implications in 
neurocysticercosis and neuroinflammatory diseases.  
 





 Inflammation in the central nervous system (CNS) is often associated with 
catastrophic neurological disabilities (87). A major component of this inflammatory 
process is a robust innate immune response by microglia and their counterparts, the 
peripherally derived macrophages that infiltrate into the brain during pathological insult 
(31, 88, 89). Indeed, microglia/macrophages are potent modulators of CNS 
repair/regeneration in several neuropathological conditions, including brain infections, 
stroke, traumatic brain injury, and spinal cord injury (1, 90). 
 Macrophages and microglia respond to environmental cues by adopting polarized 
functional phenotypes between activated M1-pro-inflammatory or M2-anti-inflammatory 
and wound healing/ tissue reparative phenotypes (49, 50, 54, 91, 92). In this regard, 
exposure to environmental factors such as pathogen-associated molecular patterns 
(PAMPs) or host molecules such as IFN-γ and TNF-α, leads to activation of STAT1 and 
NF-kB signaling cascades culminating in M1-inflammatory molecules production (51, 53, 
57). These M1 inflammatory effector cells generally promote the destruction of pathogens 
but cause widespread tissue damage when unchecked (93). On the other hand, M2 
macrophage/ microglia activation results from exposure to environmental cues such as 
cytokines IL-4 or IL-13 (M2a subtype), agonists of IL-1 receptor and TLR (M2b subtype), 
IL-10 and glucocorticoid hormones (M2c subtype), or activation of adenosine A2A 
receptors (M2d subtype recently identified in macrophages, but not in microglia) (94). In 
general, the M2 cells dampen excessive host inflammatory responses and promote tissue 
repair, including in the CNS (95, 96). Emerging evidence suggests that M2 cells are 
involved in clearance of cellular debris by phagocytosis and release tissue 
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protective/trophic factors (97, 98). Although functions of M2 subpopulations are not well 
characterized in neuropathological conditions, M2 cells promote these restorative 
processes in nervous tissue such as axonal remodeling and remyelination, 
oligodendrogenesis and neurogenesis (99). In contrast, M1-macrophage/microglia are 
found to impair these CNS repair process (90). These insights, although informative, have 
primarily been derived from in vitro studies or in vivo by selective depletion of these cells 
using chemicals. Direct mechanistic evidence showing the protective function of M2- 
macrophages/ microglia in the CNS microenvironment thus, is lacking.  
 M2-macrophage associated response is a signature of helminth infections. 
Therefore, experimental models involving helminth infections in the CNS can be important 
to identify critical molecules and mechanisms in M2- macrophage/ microglia functions to 
control brain pathology. In this regard, neurocysticercosis (NCC) is a common central 
nervous system (CNS) parasitic disease caused by the presence of Taenia solium larvae in 
the CNS (14, 100). The degree of immunological responses in CNS microenvironment 
plays a critical role in the pathogenesis of this disease (12, 17, 101). A mouse model for 
NCC, in which mice are intra-cranially (i.c.) inoculated with a related helminth 
Mesocestoides corti (M. corti), has been used to systematically characterize various aspects 
of the immune responses in the CNS microenvironment (17, 30, 43). Indeed, an absence 
of M2 activation phenotype in macrophages/ microglia in the brain of parasite-infected 
mice, as shown by us, causes severe neurological manifestations and mortality (4, 13) 
Although the factors regulating M2-microglia/macrophages functions in murine NCC 
brains are not completely understood, of particular importance are glycan antigens 
containing terminal galactose and galactosamine that are released from the parasite in the 
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CNS (17). These glycans released in the CNS microenvironment during murine as well as 
in human neurocysticercosis interact with the infiltrating macrophages (9, 102), suggesting 
a possible role for the host lectin receptors in M2- cell associated functions in the CNS, a 
highly understudied area.  
Galectins are host lectins that can recognize pathogen- or host-derived β-galactosides (74, 
75). They interact with carbohydrates through conserved carbohydrate-recognition 
domains (CRDs) and contribute to homeostatic as well as immune modulatory functions 
in several pathological conditions (103). Galectins are broadly divided into three groups: 
those containing one CRD (Galectin-1, 2, 5, 7, 10, 11, 13, 14 and 15); those containing two 
distinct CRDs (galectin-4, 6, 8, 9 and 12); and galectin-3 (73, 104). Galectin 3 is a unique 
member of the galectin family of molecules characterized by the presence of unusual 
tandem repeats of proline- and glycine-rich regions. Although there is evidence for the 
importance of galectin 3 to influence M2 macrophages development and trafficking (105), 
virtually nothing is known about its role in M2-macrophage/microglia functional 
phenotype in chronic CNS pathological conditions.  
 The goal of this study was to identify the expression and distribution of Galectin 3 
in M2-macrophage and microglia in murine model of NCC. We compared the 
susceptibility and immunopathology, including the dynamics of leukocytes infiltration in 
the CNS, between the Galectin 3-/- and WT NCC mice. As galectin-3 was primarily 
detected in infiltrating M2-macrophages, M2-macrophages from WT mice (Galectin 3 
sufficient) were adoptive transferred into the Galectin 3-/- NCC mice to analyze resolution 
of the CNS inflammation and disease severity. Based on our results from these studies, we 
report a protective role of M2-macrophage specific galectin 3 in mitigating CNS pathology 
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and disease severity, by regulating efferocytosis mediated neutrophil turnover during brain 
parasitic infection. To our knowledge, this is the first report showing a protective function 
of M2-macrophages critically regulated by galectin 3 in the CNS, in a neuropathological 
condition.  
   
Materials and Methods  
Mice and Parasite Inoculation  
 Female mice age 4-6 weeks were used in this study. Galectin 3-/- mice on C57BL/6 
were purchased from Jackson Laboratories (Bar Harbor, ME). C57BL/6 mice were 
obtained from Charles River Laboratories (Wilmington, MA) and used as wild-type (WT) 
controls. Both WT and Galectin 3-/- mice were bred in the animal facility of the University 
of North Dakota. The animals were used according to institutional and federal guidelines  
Murine model of neurocysticercosis  
 M. corti metacestodes used in this study were maintained in the peritoneal cavity 
of BALB/c mice by serial intra-peritoneal (i.p.) inoculation as described by us before (40, 
42). Mouse model of neurocysticercosis was developed as described by us (93, 106). 
Briefly, anesthetized 4-6 wk old mice were intracranially (i.c.) injected with 50 μl of HBSS 
containing about 40 parasites (103, 104). Mock control mice were i.c. injected with 50 μl 
sterile HBSS using the same protocol. Death was recorded as infection-induced mortality. 
Mice displaying severe signs of distress (non-responsiveness to cage tapping) were 
humanely sacrificed and also recorded as infection-induced mortality. To analyze various 
immunopathological parameters at indicated times post-inoculation, mice were 
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anesthetized with 100 µl of the above mixture, perfused through the left ventricle with 10 
ml cold PBS, before the brains were aseptically collected.  
Parasite burden, Histopathological and Immunofluorescence analysis 
 From the perfused control and parasite-infected mice, the brains were quickly 
dissected out, embedded in O.C.T. (optimal cutting temperature), and snap frozen. Serial 
horizontal cryosections of 10μm in thickness were placed on silane prep slides (Sigma-
Aldrich, St. Louis MO). The slides were air-dried overnight and fixed in fresh acetone for 
10s at room temperature (RT). Acetone-fixed sections were processed immediately for 
hematoxylin and eosin (H&E) or were wrapped in aluminum foil and stored at -80°C to 
perform immunofluorescence (IF) staining in future.  
 For H&E staining, after fixation in 4% formalin for 10 min at room temperature, 
slides were washed twice in deionized water, dehydrated for 30s in 100% ethanol, stained 
30s in hematoxylin, and washed in distilled water for 2 min (40, 42). Tissue sections were 
stained with eosin for 15s followed by 2 min treatment with 95 and 100% ethanol each. 
Slides were allowed to air dry, then submerged in xylene for 3 min, and mounted using 
cytoseal mounting medium (Stephens Scientific, Riverdale, NJ). The number and location 
of parasites were determined by microscopic examination of the stained tissues. Tissues 
were also analyzed for the presence or absence of infiltrating leukocytes. 
 For IF microscopy, the frozen brain tissue sections were stained with relevant 
antibodies to detect immune parameters such as galectin 3, and immune cells (107). 
Briefly, brain tissue sections were incubated with specific primary antibodies in staining 
buffer (PBS buffer with 3% host serum) to prevent non-specific binding. After 45 min of 
incubations, sections were washed seven times 3 min each in 50 mM Tris-HCl, pH 7.6 with 
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0.1% Tween-20 and incubated with appropriate secondary antibodies in staining buffer for 
30 min. Sections were then washed seven times 3 min each in 50 mM Tris-HCl, pH 7.6 
with 0.1% Tween-20. For double IF staining, the above-mentioned procedures were 
sequentially repeated for each additional staining. The sections were mounted using 
FluorSave reagent (Calbiochem, La Jolla, CA) containing 0.3 μM 4’, 6’-diamidino-2-
phenylindole (DAPI)-diacetate (Molecular Probes). Additional control staining was 
performed to rule out any nonspecific staining. In each case, sections were blocked with 
saturating concentrations of appropriate host serum antibodies to eliminate false positive 
staining due to FcR-mediated nonspecific binding. Staining in the absence of primary 
antibodies provided additional negative controls. Primary and secondary antibodies used 
for IF staining are: Rabbit anti-galectin 3 (Abcam, San Diego, CA) and Alexa Fluor® 546 
or Alexa Fluor® 488 goat anti-rabbit (Molecular Probes, OR), Rat anti-mouse 7/4 
(Cedarlane, Burlington, NC) and Alexa Fluor® 546 or Alexa Fluor® 488 Goat anti-rat 
(Molecular Probes, OR), Goat anti-mouse MGL1/2 (R&D system, Minneapolis, MN) and 
Alexa Fluor® 546 or Alexa Fluor® 488 Donkey anti-goat Alexa 488/Alexa546 (Molecular 
Probes, OR). We evaluated tissue damage on frozen brain tissue sections from control and 
parasite-infected brains by performing the terminal deoxyribonucleotidyl transferase-
mediated triphosphate (dUTP)-biotin nick end labeling (TUNEL) staining as per 
manufacturer's instructions (Chemicon International, CA). In all the cases, the images were 
acquired using a Nikon eclipse 80i upright microscope (Nikon Corporation, Tokyo, Japan) 
with an attached cooled RTke Spot 7.3 three spot color camera (Diagnostic Instruments 
Inc., Sterling Heights, MI). The images were processed and analyzed using Adobe 
Photoshop 7.0 software (Adobe, Mountain View, CA). 
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Brain mononuclear cells isolation and flow cytometric analysis  
 Leukocytes from mouse brains were isolated as described by (108). In order to 
prepare single cells suspension, each perfused brain was gently minced using Dounce 
homogenizer in 3 ml of HBSS (w/o Ca2+, Mg2+) containing HEPES (10mM) (Invitrogen, 
CA). The mixture was suspended in 30% percoll and then slowly overlaid on 70% percoll 
(GE Healthcare, CA), centrifuged at 500 x g for 30 min at RT. The interface was collected, 
pelleted at 200 x g for 5 min and re-suspended in HBSS, washed three times in 1 ml of 
HBSS with 0.1% BSA (Sigma-Aldrich), and quantified by trypan blue staining before 
performing flow cytometric analysis. Following antibodies were used for flow cytometry: 
FITC anti-mouse CD11b (clone M1/70), PE-Cy7 anti-mouse F4/80 (clone BM8), PE anti-
mouse TCR γδ (clone GL-3), PE-Cy7 anti-mouse Siglec F (clone FC50-2440), APC anti-
mouse CD206 (clone C068C2), PE anti-mouse PD-L2 (clone T425), Pacific blue anti-
mouse CD45 ( clone 30-F11) and APC anti-mouse Ly6G (Clone 1A8) antibodies (All from 
Biolegend, San Diego, CA), and PE-anti-mouse galectin 3 (clone eBioM3/38) from 
eBioscience.  
 Flow cytometric analyses for cell surface expression of relevant molecules were 
performed on a BD LSR II flow cytometer (BD Biosciences) as we have previously 
described (28). For intracellular galectin 3 staining in macrophages/ microglia, cells were 
rinsed, stained for relevant surface markers at 4°C. Cells were fixed and permeabilized 
using fixation and permeabilization buffer (eBiosciences) before intracellular galectin 3 
was detected by staining in intracellular FACS buffer (eBiosciences) containing PE anti-
mouse galectin 3 (eBiosciences) and analyzed on a BD LSRII flow cytometer.  
RNA Isolation and Quantitative Real-Time PCR (qRT-PCR) analysis 
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 The qRT-PCR analysis was performed as described by us (34, 109). Total RNA 
from mock control and parasite-infected brains were isolated using Trizol reagent 
following manufacturers' instructions (Invitrogen) and as described by us before (40, 108). 
One microgram of total RNA from each sample was reverse transcribed into cDNA by 
using a high capacity cDNA reverse transcription kit according to the manufacturers' 
instructions (Applied Biosystems, CA, and the USA). Transcript levels of galectin 3 or the 
housekeeping ribosomal 18 S RNA were analyzed by RT-PCR using specific primers: 18S 
(forward) 5'-CATGTGGTGTTGAGGAAAGCA-3' and (reverse) 
5'GTCGTGGGTTCTGCATGATG-3', galectin 3 (forward) 5′- 
CAGTGCAGAGGCGTCGGGAAA-3′ and (reverse) 5′-
CTGCCCCAGCAGGCTGGTTT-3′. Expression levels of galectin 3 were normalized to 
the mRNA level of the housekeeping 18 S RNA gene in the same sample. The fold change 
was calculated by dividing the normalized value of galectin 3 in parasite-infected brain 
samples with the corresponding normalized value in mock-infected brain samples.  
Macrophage Adoptive Transfer  
 For adoptive transfer of M1 or M2 macrophages in vivo, bone marrow cells were 
isolated from WT mice and differentiated to macrophages as previously described (34, 
110). Bone marrow-derived naïve macrophages on day 6 of differentiation were exposed 
to IFNγ (20ng/ml, Peprotech) or to IL-4 (20ng/ml) to generate the M1-inflammatory or 
M2-antiinflammatory phenotype respectively in vitro (92, 111). M1 macrophages were 
labeled with Cell-tracker orange CMTMR (Life technologies) and M2 macrophages were 
labeled with Carboxyfluorescein succinimidyl ester (CFSE cell proliferation kit Life 
technologies) CellTracker at 37°C for 15 min as described by us before (112). 5x106 
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labeled cells were then injected intravenously via tail vein (112) into WT and Galectin 3-/- 
mice i.c. infected with M. corti for 6d prior to transfer. As control, WT and Galectin 3-/- 
mice undergoing NCC in same experimental set up were injected with vehicle only. 
Twenty-four hours after transfer, brains were harvested and processed for various 
immunopathological analysis on parameters described in results section by following 
above mentioned experimental protocols.  
Ex-vivo Efferocytosis 
 For these studies, peritoneal neutrophils were isolated from WT mice 12-16hr after 
intraperitoneal injection of sterile 4% thioglycollate (BD Biosciences, San Jose, CA) (46). 
For macrophages, WT and Galectin 3-/- mice were injected i.p. with 4% thioglycollate on 
day-0. On day-0 and day-2 mice were injected i.p. IL-4c mixture containing 5 µg of 
recombinant murine IL-4 (Peprotech) and 25 µg of anti-IL-4 mAB (11b11, BioXcell), 
whereas control animals received the vehicle, PBS. On day-4 peritoneal exudate cells 
(PECs) were harvested and macrophages were analyzed for expression of M1/ M2 
mediators by flow cytometry and RT-PCR before they were used for efferocytosis analysis 
ex vivo. To compare efferocytosis by M2 macrophages induced by parasite infection, WT 
and Galectin 3-/- mice were infected i.p. with M. corti (60-100 in numbers) and PECs were 
harvested after 4-5wk p.i. to collect M2 cells. Mock control mice instead received vehicle 
(PBS). On day-4 PECs were harvested to purify naïve macrophages for their role in this 
process. To obtain neutrophils, WT mice were injected i.p. with 4% thioglycollate for 16-
18 hours.  
 The purity of the cells was ascertained by flow cytometry analysis (Ly6G+ 
neutrophils 80-85%; F4/80+ macrophages 85-90%). Isolated neutrophils were labeled with 
 
34 
Carboxyfluorescein succinimidyl ester (CFSE; Cell Trace™ CFSE Cell Proliferation Kit 
from Invitrogen). Macrophages seeded on 6 well plates (1x106 cell/ml) were incubated 
with CFSE-labeled neutrophils at a ratio of 5:1(neutrophils: macrophages). After 2 hrs of 
efferocytosis, non-internalized neutrophils were removed by washing thoroughly. 
Macrophages were scraped and stained with F4/80 and Ly6G antibodies for flow 
cytometry. Gating scheme to quantitate Ly6G-F4/80+ CFSE+ efferocytic macrophages 
that had internalized labeled neutrophils is shown in Figure.II-8. For individual 
experiments, efferocytic index was calculated as percentage of Ly6G-F4/80+CFSE+ 
macrophages from WT and Galectin 3-/- mice that engulfed neutrophils (112). 
Statistical Analysis  
 The survival of the infected WT and Galectin 3-/- mice was compared using Log-
rank (Mantel-Cox) Test. The statistical comparison between levels of host mediators was 
done with Student’s t test using Sigma Plot 8.0 
H&E and Immunofluorescence Staining  
 Parasite and HBSS infected brains were immediately removed from perfused WT 
and Galectin 3-/- mice, embedded in OCT resin and snap frozen. Serial horizontal cryo-
sections with 10um in thickness were positioned on silane prep slides (from Sigma-Aldrich, 
St. Louis, MO). Every 5th slides were sectioned and stain following the H&E staining 
protocol previously described  
Quantitative Real-time PCR  
 Brain from infected and mock control mice 1 WK and 3 WKS post infection were 
directly perfused and the total RNA was extracted using trizol reagent (Invitrogen) 
according to the manufacturer’s instructions. Real-time PCR analysis of the samples was 
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done using SYBRO green (Applied Biosystems, CA (USA). Transcript levels of the 
housekeeping ribosomal 18S ,Galectin 9 gene Galectin 3 genes were measured in each 
sample by PCR amplification using specific primers: removed 18S (forward) 5'-
CATGTGGTGTTGAGGAAAGCA-3' and (reverse) 5'GTCGTGGGTTCTGCATGATG-
3'; Galectin 9 (forward) 5'- TCAAGGTGATGGTGAACAAGAAA-3’ and (reverse) 5’- 
GATGGTGTCCACGAGGTGGTA -3’;Gal3 Galectin 3 (sense) 
5′CAGTGCAGAGGCGTCGGGAAA-3′ and (anti-sense) 
5′CTGCCCCAGCAGGCTGGTTT-3′ 
Statistical Analysis  
 The survival of the infected WT and Galectin 3-/- mice was compared using Log-
rank (Mantel-Cox) Test. The statistical comparison between levels of host mediators was 




Galectin 3 is abundantly expressed in M2 macrophage recruited into the CNS 
during murine NCC  
To examine the role of galectin 3 in parasite-infected brains, its transcript-level of 
expression was determined by qRT-PCR using RNA from mock and M. corti i.c. infected 
brains. Increased mRNA expression of galectin 3 was observed at both 1wk and 3wk p.i. 
over mock control (~ 27-fold increase at 1wk p.i. and ~14-fold increase at 3wk p.i) 
(Figure.II-1A). To identify the cell-specific expression of galectin 3 protein, in-situ co-
immunostaining was performed on brain cryosections of mock control and parasite-
infected mice. In mock-infected mice brains, galectin 3 was scarcely detected (Figure.II-
1B). In contrast, parasite-infected brains exhibit abundant galectin 3 protein expression at 
both 1wk and 3wk p.i. (Figure.II-1B & C). Double IF staining on the parasite-infected brain 
sections showed an accumulation of large numbers of round monocyte/ macrophage-like 
CD11b+ or F4/80+ cells in meninges and ventricles that displayed positive staining for 
galectin 3 (Figure.II- 1C). We have previously reported that the infiltrating macrophage in 
the CNS of mice undergoing NCC display M2-, but not M1- activation phenotype (40, 42, 
43, 58). Indeed, the MGL1/2+ infiltrating macrophages were stained positive for galectin 
3 (Figure.II- 1D), suggesting that the M2- macrophages accumulating in the CNS during 
parasite infection abundantly express galectin 3. In addition, some microglia cells as 
determined by CD11b+ staining combined with typical cell morphology and brain 
anatomical location exhibited galectin 3 expression (data not shown). Galectin 3 protein 
expression was largely undetected in other nervous tissue or immune cell types e.g. CD11c 
(dendritic cells), ᾳβT cells, γδT cells, neutrophils (7/4), B-cells (CD19) (data not shown).  
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To further characterize the cell-specific expression of galectin 3 in infiltrating 
macrophage and/ or microglia as well as to identify its cellular localization, the flow-
cytometric analysis was performed. It is important to note that CD45hiF4/80+ cells in the 
CNS are known to be infiltrating macrophages, whereas CD45intF4/80+ cells represent as 
microglia. Consistent with IF microscopy analysis, galectin 3 was primarily detected in 
CD45hiF4/80+ macrophages in the CNS at both 1wk and 3wk p.i. (Figure.II-2B & 2C). In 
contrast, only 7% of CD45intF4/80+ that are presumably microglia, displayed galectin 3 
positive staining (Figure.II-2B & 2C). Interestingly, the majority of the CD45hiF4/80+ 
cells exhibited intracellular staining of galectin 3 (Figure.II-2B & C). In both 1wk and 3wk 
p.i. mice brains, 80–90% of the CD45hiF4/80+ cells were MGL1/2+ or PD-L2+ (data not 
shown), indicating that the galectin 3 expression is largely localized to the M2 
macrophages in the CNS of M. corti i.c. infected mice undergoing NCC.  
Galectin 3-/- mice exhibit increased disease severity during murine NCC 
In light of abundant expression of galectin 3 in M2 macrophages, we sought to 
examine the role of galectin 3 in overall disease severity during parasite infection of the 
brain. For this, the development of neurological signs and survival of WT and Galectin 3-
/- was compared. Neurological signs related to i.c. M. corti infection including abnormal 
vestibular function, tilted head, and cerebral abnormalities were observed between 2-3wk 
p.i. in WT mice. However, infected Galectin 3-/- mice displayed these signs much earlier 
and were more accentuated between 2-3wk p.i. Importantly, M. corti-infected Galectin 3-/- 
mice exhibited decreased survival as compared to the WT (Figure.II- 3A). At 3wk p.i., only 
40% (4 of 10) of the M. corti i.c. infected Galectin 3-/- survived the CNS infection as 
opposed to 100% (9 of 9) of the WT mice (Figure.II- 3A, p<0.005). Together these data 
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suggest a protective role of galectin 3 in the pathogenesis of CNS parasite infection, 
possibly relating to its expression in the infiltrating M2 macrophages in the CNS. 
Galectin 3-/- mice exhibit no defect in parasite clearance or their segregation  
Microscopic analysis of the H&E stained serial brain cryosections was performed 
to determine the clearance of parasites and/ or their extravasation into specific CNS areas 
in the absence of galectin 3. No statistically significant difference in the parasite loads was 
observed in the CNS of WT and Galectin 3-/- NCC mice at 1wk and 3wk p.i. (Figure.II-
3B). Moreover, brain parenchyma or extra-parenchyma of WT and Galectin 3-/- mice at 
1wk and 3wk p.i. exhibited no statistically significant difference in parasite count 
(Figure.II-3B), although the Galectin 3-/- mice tended to exhibit a relatively lower number 
of organisms in extra-parenchymal regions (Figure.II- 3B2). Thus, the protective function 
of galectin 3 did not appear to relate to parasite clearance and/ or their segregation to 
specific CNS sites of infected mice. 
 Galectin 3-/- mice exhibit severe neuropathology 
We evaluated the gross CNS immunopathological changes in mock and i.c. M. 
corti-infected WT and Galectin 3-/- mice. H&E stained brain cryosections of the control 
animals of both strains that were i.c. inoculated with HBSS, displayed similar normal brain 
tissue morphology with scarce presence of immune cells (Figure.II- 3C). In the parasite-
infected WT mice brains, presence of mixed leukocyte subsets were detected. A majority 
of these infiltrating cells appeared to be monocyte/ macrophages at both 1wk and 3wk p.i. 
(Figure.II- 3C, inset). In contrast, infected Galectin 3-/- mice brains appeared to exhibit an 
increased CNS inflammation with transiently higher numbers of infiltrating immune cells 
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compared to WT mice. In addition to the high numbers of immune cells with morphology 
consistent with monocytes/ macrophages, polymorphonuclear cells (PMNs) were 
abundantly detected between 2-3wk p.i. in Galectin 3-/- mice compared to their WT 
counterparts (Figure.II- 3C, insert, shown at 3wk p.i.). To examine the impact of Galectin-
3 deficiency on the tissue pathology, TUNEL staining was performed on the brain tissue 
sections of WT and Galectin 3-/- mice. Very little to no TUNEL positive cells were detected 
in the CNS of mock and at 1wk p.i. in WT and Galectin 3-/- mice (data not shown). At 3wk 
p.i. the TUNEL staining remained low in the WT brains, which was in contrast to the 
Galectin 3-/- brains that displayed increased TUNEL detected staining at that time p.i. 
(Figure.II- 3D). Interestingly, this increased TUNEL staining was detected in immune cells 
present in the extra-parenchymal regions and surrounding nervous tissue cells in the CNS 
of Galectin 3-/- mice. These data suggest that absence of galectin 3 dependent responses 
leads to greater CNS inflammatory pathology during NCC. 
To further examine the impact of galectin 3 deficiency on inflammatory response, 
levels of multiple inflammatory cytokines and chemokines in brain homogenates were 
compared between WT and Galectin 3-/- mice i.c. inoculated with HBSS or M. corti. 
(Figure.II- 4). CBA analysis for key inflammatory molecules TNF-ᾳ, IL-1β, and IL-12p70 
showed low basal levels of these cytokines in WT and Galectin 3-/- mice brains (Figure.II- 
4). In contrast, M. corti-infected WT and Galectin 3-/- mice brains exhibited increased 
levels of these mediators at 1wk and 3wk p.i., albeit there were no statistically significant 
differences in IL-1β, and IL-12p70 levels between infected Galectin 3-/- and WT mice 
(Figure.II- 4). TNF-ᾳ was detected at a lower level in Galectin 3-/- mice at 3wk p.i., 
compared to the WT counterparts (Figure.II- 4). On the other hand, significantly higher 
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levels of neutrophil chemo-attractants (CXCL1, CXCL2), and monocyte/ macrophage 
chemo-attractants (CCL2, CCL4) were detected in the brain homogenates of parasite-
inoculated Galectin 3-/- mice at 1wk p.i. compared to the WT. Intriguingly, no significant 
differences in the levels of these chemokines were detected in the CNS of Galectin 3-/- mice 
at 3wk p.i. (Figure.II- 4), a time of peak disease severity displayed by them. Our results 
suggest a possibility of higher accumulation of PMNs together with increased cell death in 
the CNS to be likely the cause of enhanced disease severity observed in Galectin 3-/- mice 
after brain parasite infection.  
Galectin 3-/- mice display increased neutrophil and M2 macrophage accumulation in 
the CNS after parasite infection 
Majority of the immune cells recruited to the brain after parasite infection are 
macrophages (2-3d p.i.), γδ T cells (3-5 days p.i), dendritic cells (1wk p.i.), ᾳβ T cells (1wk 
p.i) and B-cells (3wk p.i.) (40, 42, 43, 58). In the M. corti infected brains, macrophages are 
the most predominant leukocyte populations, whereas neutrophils are detected in relatively 
in low numbers throughout the infection process (27). Within this context, H & E analysis 
of the brain cryosections of M. corti parasite infected Galectin 3-/- mice appeared to display 
a massive increase in numbers of infiltrating cells with morphology consistent with 
neutrophils (Figure.II-3C). To determine whether a deficiency of galectin 3 alters 
neutrophil numbers in the CNS, the expression of neutrophil marker 7/4 was analyzed by 
in situ IF microscopy. In mock-infected brains of both WT and Galectin 3-/- mice, 7/4+ 
cells were scarcely detected (Figure.II- 5A). In the WT brain at 1wk p.i. little change in the 
numbers of 7/4+ cells was detected as compared to the mock control mice, which increased 
by 3 wk p.i.. Galectin 3-/- brains, on the other hand, exhibited a massive increase in 7/4+ 
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cells at 3wk p.i. as compared to WT mice (Figure.II- 5A). This suggested that absence of 
galectin 3 cause increased of neutrophils accumulation in the infected brain.  
Next, flow cytometry analysis was performed to enumerate immune cells 
infiltrating the CNS of Galectin 3-/- and WT infected mice. Mononuclear cells from the 
whole brain were isolated at an early stage of infection (1wk p.i.) and at the peak of 
inflammation (3wk p.i.) (Figure.II- 5 and Figure.II- 6). The numbers of neutrophils in the 
CNS of Galectin 3-/- and WT infected mice were determined by quantifying 
Ly6G+CD11b+ cells. Consistent with the results from IF microscopy analysis, we found 
no significant differences in the percent as well as absolute numbers of CD11b+Ly6G+ 
neutrophils in the CNS of parasite-infected Galectin 3-/- mice compared to the WT at 1wk 
p.i. (Figure.II-5B). However, at 3wk p.i. the numbers of Ly6G+CD11b+ neutrophils were 
significantly increased in the CNS of parasite-infected Galectin 3-/- mice as compared to 
the WT mice (Figure.II-5B), confirming that galectin 3 deficiency leads to increased 
accumulation of neutrophils in the CNS microenvironment during chronic infection. We 
found no significant differences in the numbers of dendritic cells (CD11c+), γδ T cells 
(TCRδ+), αβ T cells (TCRβ+) or B cells (CD19+) at 1wk or 3wk p.i. CNS of Galectin 3-/- 
and WT mice (data not shown). To determine if the infiltration of M2 macrophages is 
affected in the absence of galectin 3, the numbers of MR1+ or PD-L2+ was enumerated as 
we previously have shown MR1 is upregulated on M2 macrophages in parasite-infected 
brains whereas PD-L2 is a well-known marker of M2 cells (29, 43). Indeed, 
CD45hiF4/80+MR1+, as well as CD45hiF4/80+PD-L2+ M2 macrophages, were detected at 
both higher percentage and numbers in the CNS of infected Galectin 3-/- mice at 1wk and 
3 wk p.i. as compared to their WT counterparts (Figure.II- 6A& 6B). This increased 
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accumulation of M2-macrophages in the CNS of parasite-infected Galectin 3-/- mice was 
statistically significant. Together our data suggested that galectin 3 in M2 macrophages 
likely plays a role in containment of neutrophilia in the CNS.  
Adoptive transfer of M2-macrophage from WT mice reduces neutrophilia in the 
CNS and improves disease severity in recipient Galectin 3-/- mice during brain 
parasitic infection 
Galectin 3 was found to be expressed primarily in infiltrating M2 macrophage in the 
CNS of M. corti i.c. infected mice. Because Galectin 3-/- NCC mice exhibited neutrophilia 
and severe disease signs, we sought to examine if the adoptive transfer of galectin 3 
sufficient M2-macrophages improves the disease severity. The effect on neutrophil 
turnover in the CNS and disease severity was compared WT and Galectin 3-/- mice after 
adoptive transfer of WT M2 macrophages. In initial experiments, macrophages were 
isolated from the brains of i.c. infected WT mice to use as donor cells. However, even 
though macrophages are the most predominant immune infiltrating cells found in the 
parasite-infected WT mouse brains, it was difficult to isolate sufficient numbers of these 
cells from the brain to perform adoptive transfer experiments in different groups. Thus, 
naïve bone marrow-derived macrophages were polarization to the M2- phenotype using 
well-characterized stimulus IL-4 for adoptive transfer experiments. M2- phenotype of 
these cells was verified by analyzing M2-markers Arginase-1 and CCL24, but not NOS2 
expression in these cells (data not shown). The M. corti i.c. infected WT and Galectin 3-/- 
NCC mice received vehicle or WT-M2 cells i.v. at 1wk, and 2wk p.i. followed by analysis 
of neutrophils numbers in the CNS of recipients. Flow cytometry analysis revealed that the 
i.v. injected WT-M2 cells migrated into the CNS microenvironment of the recipient 
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Galectin 3-/- or WT mice with similar relative efficiency (Supplementary Figure II. S1). 
Indeed, more than 50% of the CFSE labeled WT-M2 cells (F4/80+CFSE+) injected i.v. 
migrated into the CNS of the infected recipient mice at 24-h post adoptive transfer (Figure. 
S1). In-situ IF microscopy with anti-7/4 was performed on brain cryosections from 
recipient mice at 3wk of NCC to detect the accumulation of neutrophils. Transfer of WT-
M2 (experimental Group: WT NCC-WT M2) or vehicle (experimental Group: WT NCC-
Vehicle) into the i.c. infected WT mice caused no apparent change in the number of 7/4+ 
neutrophils accumulated in the CNS (Figure.II- 7B). On the other hand, infected Galectin 
3-/- mice i.v. injected with vehicle (experimental Group: Galectin 3-/-NCC-Vehicle) at 1wk, 
and 2wks p.i., revealed the abundant presence of 7/4+ neutrophils in the CNS which was 
substantially more compared to the experimental Group: WT NCC-WT M2 (Figure.II- 7B). 
Importantly, transfer of WT M2 cells into i.c. infected Galectin 3-/- mice (experimental 
Group: Galectin 3-/-NCC- WT M2) resulted in a significant decrease in the number of 7/4+ 
neutrophils accumulated in the CNS as compared to the Galectin 3-/-NCC mice that 
received vehicle only (Figure.II- 7B). These results confirmed that Galectin 3 expressing 
M2-macrophages regulate neutrophilia in the CNS during brain parasitic infection.  
To determine whether adoptive transfer of galectin 3 sufficient WT-M2 cells would 
prevent disease severity in Galectin 3-/- NCC mice, WT and Galectin 3-/- mice inoculated 
i.c. with M. corti were i.v. injected with vehicle or WT M2 cells at 1wk, and 2wks p.i. as 
discussed above. WT NCC-Vehicle displayed typical neurological signs (abnormal 
vestibular function, tilted head, and cerebral abnormalities) by 3wk p.i.. These infection 
induced disease signs appeared earlier and were more pronounced in Galectin 3-/-NCC-
vehicle group of mice. In addition, these Galectin 3-/-NCC that received vehicle exhibited 
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decreased survival (Figure.II-7D). By 26 days p.i, % of M. corti-infected WT mice Galectin 
3 was found to be expressed primarily in infiltrating M2 macrophage in the CNS of M. 
corti i.c. infected mice. Because Galectin 3-/- NCC mice exhibited neutrophilia and severe 
disease signs, we sought to examine if adoptive transfer of galectin 3 sufficient M2-
macrophages improves the disease severity. The effect on neutrophil turnover in the CNS 
and disease severity was compared WT and Galectin 3-/- mice after adoptive transfer of 
WT M2 macrophages. In initial experiments, macrophages were isolated from the brains 
of i.c. infected WT mice to use as donor cells. However, even though macrophages are the 
most predominant immune infiltrating cells found in the parasite-infected WT mouse 
brains, it was difficult to isolate sufficient numbers of these cells from the brain to perform 
adoptive transfer experiments infected Galectin 3-/- mice (experimental Group: Galectin 3-
/-NCC- WT M2) resulted in a significant decrease in the number of 7/4+ neutrophils 
accumulated in the CNS as compared to the Galectin 3-/- NCC mice that received vehicle 
only (Figure.II-7B). These results confirmed that galectin 3 expressing M2-macrophages 
regulate neutrophilia in the CNS during brain parasitic infection. By 26 days p.i, %25 of 
M. corti-infected WT mice succumbed to the infection as compared to 80% of Galectin 3-
/- mice (4of 5) (Figure.II- 1, p<0.005). In contrast, none of the Galectin 3-/-NCC-WT M2 
mice exhibited severe neurological signs during the 3wk p.i. and all survived the infection. 
This data strongly showed that adoptive transfer of Galectin 3-sufficient M2-MФ 
ameliorated disease severity and improved survival during CNS parasite infection in 
Galectin 3-/- mice.  
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Galectin 3-/- M2-MФ exhibit impaired efferocytosis of neutrophils 
A prominent anti-inflammatory and tissue reparative function of M2-macrophages 
is efferocytic clearance of infiltrating immune cells (97, 98, 113, 114). In order to gain 
mechanistic insights into the role of Galectin 3 expressed in M2-MФ in regulating 
neutrophil accumulation in helminth-infected brains, we compared ex-vivo efferocytosis 
of CFSE- labeled neutrophils by M2-macrophages from WT and Galectin 3-/- mice by flow-
cytometry (Figure.II-8). For this, Galectin 3-/- and WT peritoneal M2-macrophages isolated 
from the M. corti i.p. infected (Figure.II-8B) or thioglycollate + IL-4 complex i.p. injected 
mice (Figure.II-8C) were incubated with CFSE labeled neutrophils. M2-phenotype of 
macrophages was ensured by flow cytometry analysis of differential expression of M1/M2 
markers PD-L2, MR-1, ARG-1, and NOS2, as described above. As shown in (Figure.II- 
8B and 8B’), after 3 hrs of incubation, efferocytic uptake of CFSE-labelled neutrophils was 
significantly less in Galectin 3-/- M-macrophages as compared to their WT counterparts. 
Similar results were obtained with WT and Galectin 3-/- M2 macrophages differentiated 
with peritoneal injection of IL-4 complex (Figure.II- 8C and 8C’). These data strongly 
suggested that galectin 3 expression in M2-macrophages is required for efferocytic uptake 




Increasing evidence from several experimental neuropathological models such as in 
traumatic brain injury suggests that M2-macrophage are the first to infiltrate into CNS 
tissues (97, 115). As the injury persists, a shift to increased accumulation of M1 phenotypic 
macrophages in the CNS coincides with the inflammatory pathologic phase (94). Whereas 
regulatory immune mediators such as IL-10, TGF-β have been implicated in M2 cells 
mediated immune suppression/ anti-inflammatory response, important central regulatory 
mechanisms involved in M2-macrophage functions to contain CNS inflammation and 
pathology need to be identified. The data presented here show that during brain helminth 
infection of the CNS, cytosolic galectin 3 is increased specifically in M2 macrophages, but 
not substantially in microglia. Concomitantly, absence of galectin 3 resulted in a massive 
increase in the accumulation of neutrophils correlating with heightened disease severity in 
M. corti infected Galectin 3-/- mice as compared with WT mice. Galectin 3 deficiency in 
M2-macrophages decreased efferocytic clearance of neutrophils by these cells. 
Importantly, pathological sequelae, including severe neutrophilia in CNS parasite infected 
Galectin 3-/- mice, were ameliorated by adoptive transfer of Galectin 3 sufficient M2 
macrophages. Our study shows, for the first time, a protective role of M2-macrophage 
associated galectin 3 in brain parasitic infection by controlling neutrophil turnover in the 
CNS. There has been a growing appreciation for a role of macrophage/ microglia with M2 
functional phenotype having a profound role in different aspects of CNS repair and 
containment of immunopathology in the brain (90). Indeed, results from our previous 
studies with STAT6-/- or TLR2-/- mice provide direct evidence for the critical protective 
role of the myeloid cells with M2 functional phenotype in the brain microenvironment, 
during CNS parasite infection (13, 43). Here we observed that the parasite-infected 
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Galectin 3-/- mice, despite showing the presence of an increased number of M2-
macrophages in the CNS compared to their WT counterparts, exhibit severe neurological 
signs and are highly susceptible to the infection. In the CNS of Galectin 3-/- mice, perhaps 
the observed elevated amount of the chemokines including, CCL2 that are known to 
involve in trafficking of monocytes/ macrophages (116, 117), facilitates the increased 
influx of M2 cells. This indicated to us that the protective function, but not the 
development, of M2-cells is dependent on galectin 3. Indeed, in the parasite-infected 
brains, galectin 3 was primarily detected in infiltrating M2 macrophages and the transfer 
of Galectin 3 sufficient M2 macrophage from WT mice reversed the infection-induced 
CNS pathology and improved the survival of parasite-infected Galectin 3-/- mice. These 
results highlight the importance of galectin 3 in M2 macrophages mediated protective 
functions to contain CNS pathological process. However, it remains to be determined the 
consequence as well as the mechanisms involved in the increased accumulation of M2-
macrophages in the CNS of parasite-infected Galectin 3-/- mice. In this regard, it has been 
suggested that galectins, including galectin 3, can play a role in immune cell trafficking 
(118-120). However, our results showed that adoptively transferred galectin 3 sufficient as 
well as -deficient M2-macrophages accumulated in the CNS of both WT and Galectin 3-/- 
mice with similar frequency. This strongly supports the idea that the enhanced disease 
severity in Galectin 3-/- NCC mice was a direct consequence of a lack in the galectin 3 
mediated response from M2 cells, but not due to a defect in M2 macrophage development 
or trafficking (105, 120). In M. corti- infected WT mice brains neutrophils were detected 
as a minor proportion of the immune cells present in the brain of M. corti- infected WT 
mice. Earlier studies have also identified similar low numbers of neutrophils in the CNS 
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microenvironment during murine NCC (30). However, infected brains in Galectin 3-/- mice 
display a massive increase in the number of neutrophils as compared to the WT mice, 
suggesting a role for galectin 3 in regulating neutrophil turnover. The transfer of M2-
macrophage from WT could reverse this increased of neutrophil accumulation in the CNS 
microenvironment of M. corti –infected Galectin 3-/- mice, thus providing additional 
support for a role of galectin 3 in M2 macrophage-mediated containment of neutrophilia. 
This observation is exciting, as the absence of M2-macrophages has been shown to 
associate with increased neutrophilia and reduced eosinophilia during infection with a 
nematode parasite, Brugia malayi, but the mechanism remained unknown (3). Indeed, in 
M. corti i.p. infected Galectin 3-/- mice, we observed a reduced eosinophilia coinciding with 
the increased neutrophilia (data not shown) further supporting a fundamental role of M2 
macrophage-associated functions of galectin 3 in controlling neutrophilia. Although the 
molecular pathway of galectin 3 mediated containment of neutrophilia in the CNS 
microenvironment remains to be determined, our data showing a defect in efferocytosis of 
neutrophils by Galectin 3-/- M2 macrophages in vitro suggests its regulatory role in 
efferocytic ability of these cells. In this context, a recent report has suggested that galectin 
3 expressed and secreted by neutrophils auto-regulate their turnover during a self-resolving 
model of peritonitis with zymosan injection (82). It has further been suggested that galectin 
3 secreted by neutrophils facilitates efferocytosis of these cells by interacting with its ligand 
on macrophage surface (65). However, the data from our studies clearly suggested a 
cytosolic, but not extracellular presence of galectin 3 in M2 macrophages in parasite-
infected brains. Moreover, if secreted galectin 3 was involved in containing neutrophilia in 
parasite-infected brain, we would expect to detect galectin 3 on the surface of macrophages 
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and/ or neutrophils, which was not the case. Thus, galectin 3 in M2 macrophages regulates 
neutrophil turnover by efferocytosis in the CNS microenvironment. The findings that 
several signature inflammatory mediators are present at a similar level in the CNS Galectin 
3-/- mice despite exhibiting low survival raised the fundamental question of whether M2 
subsets are sufficient to contain NCC and other CNS pathological conditions. Indeed, in 
human NCC patients the hyper-inflammatory responses in the CNS thought to contribute 
to tissue pathology and mortality (121). Thus, along with anti-parasitic drugs, treatment of 
NCC patients with immunosuppressive/anti-inflammatory factors such as corticosteroids 
is frequently used to control the associated neuropathology, despite the life-threatening side 
effects associated with long-term treatments with steroids (82). Within that context, we and 
others have shown a decreased expression of the inflammatory mediators in M. corti 
infected γδT-/- or MyD88-/- mice is associated with reduced pathology and longer survival 
times. But, despite presence of lower brain levels of these inflammatory mediators, M. corti 
infected TLR2-/- mice presented an increased CNS pathology and disease signs (13). We 
have also shown that the reduced numbers of M2 macrophages observed in TLR2-/- mice, 
and more importantly in the CNS of STAT6-/- mice, coincided with severe disease signs in 
murine NCC (42). Thus, the findings from these studies that galectin 3 can profoundly 
influence M2- macrophage cell functions in the CNS may be directly relevant to human 









Figure II- 1.  Expression and distribution of galectin 3 in the parasite-
infected brains. 
 
Quantitative RT-PCR analysis and IF microscopy were performed on parasite-infected and mock 
control mice i.c. injected with helminth parasite M. corti. (A) The total RNA was extracted from the 
brains at 1wk and 3wk post inoculation and mRNA expression of galectin 3 was measured by qRT-
PCR as described in Methods. The fold changes in parasite-infected brains were calculated over the 
levels in mock control mice using the formula 2−(ΔΔCt). Data shown are the mean ± SEM of 3–4 mice 
per time point in two independent experiments. (B1& B2) Double immunofluorescence staining was 
performed on brain tissue cryosections from mock or parasite- infected C57/BL6 mice. Nuclei (blue) 
were stained with 4’6’ diamidino-2-phenylindole-dilactate (DAPI). Galectin 3 was stained using an 
affinity purified anti-mouse galectin 3 goat IgG followed by Alexa Fluor® 488 labeled (Green) goat 
anti-rabbit IgG. (B3) galectin 3 expression was co-visualized with macrophages using an affinity 
purified anti-mouse F4/80 Alexa Fluor® 488 labeled (Green) or (B4) MGL1/2+ cells using an 
affinity purified anti-mouse MGL1/2 goat IgG followed by Alexa Fluor® 546 labeled (red) donkey 
anti-goat IgG. Images shown are representative of 3 independent experiments with 3–4 mice each. 











Figure II- 2.  Infiltrating M2 macrophages in the parasite-infected brains express 
galectin 3 in the cytosol, but not on cell surface.  
 
Mice were injected i.c. with HBSS (mock) or 60 helminth parasite (infected), and brain 
mononuclear cells were isolated at 3wk post inoculation. (A) Gating scheme to select 
C45hiF4/80+Galectin 3 positive cells. Collected cells with gated with FSC and SCC 
Singlet cells. The cells were then gating on CD45 and F4/80 and galectin 3 positive cells.  
(B) Representative FACS plots gated on CD45hi and F4/80+ (infiltrating macrophages) or 
gated on CD45int and F4/80+ (microglia) cells from individual mouse brain showing 
intracellular or cell surface expression of galectin 3. (C) Quantification of galectin 3 
expression in CD45hiF4/80+ macrophages or CD45intF4/80+ microglia. Results are 












Figure II- 3.  Galectin 3-/- mice exhibit reduced survival and increased brain 
pathology despite exhibiting similar parasite burden as the WT mice. 
 
(A) WT and Galectin 3-/- mice were i.c. infected with 60 M. corti and were assessed daily 
for disease severity. The survival was monitored for 3 weeks post inoculation. Statistical 
comparison of susceptibility was done by Log-rank (Mantel-Cox) Test, p= 0.0047 **, 
n=9-10. (B) Number of parasites at 1wk and 3wk p.i. in parenchymal (P) and extra 
parenchymal (EP) regions in individual Galectin 3-/- and WT brains were calculated by 
microscopic examination of serial H&E-stained brain sections. The bars show average +/- 
SEM parasites from 5-6 mice per group. (C) Representative microscopic evaluation of 
H&E stained brain cryosections from WT and Galectin 3-/- mice i.c. injected with HBSS 
(mock) or with 40 parasites at indicated times p.i.. Magnification 200X. (D). IF 
microscopy analysis was performed on brain cryosections from WT and Galectin 3-/- 
mice i.c. infected with 60 M. corti parasites to detect TUNEL positive staining (Red). 
Nuclei (blue) were stained with 4’6’ diamidino-2-phenylindole-dilactate (DAPI). Images 













Figure II- 4.   Inflammatory mediators in the CNS of parasite-infected Galectin 3-/- 
and WT mice.  
 
The brains from mock control and M. corti infected WT and Galectin 3−/− mice were 
harvested at 1wk and 3wk i.c., homogenized, and the protein level of host immune 
mediators measured by CBA using flow cytometric analysis (BD Biosciences). Results 
shown are mean ± SEM of 3–4 each infected and mock control mice from 2–3 










Figure II- 1.  Parasite-infected Galectin 3-/- mice exhibit increased neutrophil 
accumulation in brain.  
 
(A)IF microscopy on brain cryosections from WT and Galectin 3-/- mice i.c. injected with 
HBSS (mock) or with 60 parasites at 1wk and 3wk i.c. Neutrophils (7/4+) were detected 
by using an affinity purified anti-mouse 7/4 goat IgG followed by Alexa Fluor® 546 
labeled (red). Nuclei (blue) were stained with 4’6’ diamidino-2-phenylindole-dilactate 
(DAPI). Images shown are representative of 3 independent experiments with 3–4 mice 
each group.(B) Flow cytometry analysis of CD11b and Ly6G on brain mononuclear cells 
harvested From mock control and M. corti infected WT and Galectin 3−/− mice at 1wk 
and 3wk i.c. The cells were double-stained with anti-Ly6G-APC and anti-CD11b-Pacific 
Blue Antibodies as markers for neutrophils. Representative contour plots show  
CD11b+Ly6G+ neutrophils in brains of parasite-infected WT and Galectin 3−/− mice. The 
bar graph on the right shows mean ± SEM of percent of CD11b+Ly6G+ neutrophils in 
brains of M. corti infected WT and Galectin 3−/− mice each from 3 independent 














Figure II- 6.  Parasite-infected Galectin 3-/- mice exhibit increased M2 macrophages 
accumulation in brain  
 
(A) Flow cytometry analysis of CD45, F4/80 and Mr-1 or (B) CD45, F4/80 and PD-L2 
on brain mononuclear cells harvested from mock control and M. corti infected WT and 
Galectin 3-/- mice at 1wk and 3wk i.c. The cells were with anti-CD45-Pacific Blue, anti-
F4/80-PE-cy7, anti-MR-1-APC and PD-L2-PE antibodies as markers for infiltrating M2 
macrophages in brains of M. corti infected WT and Galectin 3-/- mice each from 3 


















Figure II- 7.  Galectin 3 expressing M2 macrophages exhibit protective role during 
NCC infection.  
 
(A)Schematic representation of the adoptive transfer experiment as described in the 
Methods. Purified bone marrow macrophages from WT mice were differentiated to M2 
phenotype by exposure to IL-4 in vitro. These M2-macrophages or vehicle alone were 
injected i.v. into WT or Galectin 3-/- recipient mice at 1wk and 2wk of i.c. infection with 
M. corti. Survival of mice, brain tissue pathology and neutrophil accumulation in the 
CNS were compared to 3wk i.c. (B) Top panel shows representative images of H&E 
stained brain cryosections. Bottom panel show IF microscopy images of brain  
cryosections to compare accumulation of 7/4+ (green) neutrophils. (C) Bar graph 
showing 7/4+ neutrophils manually counted from images shown in (B). (D) The survival 
of NCC-WT or NCC-Galectin 3-/- mice adoptively transferred with WT-M2 macrophages 
or vehicle was monitored for three weeks. Statistical significance was determined by 













Figure II- 8.  Galectin 3-/- M2-macrophage exhibit reduced efferocytosis of 
neutrophils ex-vivo  
 
(A). Gating scheme to select efferocytic cells. singlet cells gated on FSC-H and FSC-A 
and the Ly6G negative to eliminate untaken neutrophils that may be on the surface of 
macrophages and CFSE positive to quantify the macrophages that internalized the 
neutrophils (Ly6G-F4/80+ CFSE+ cells) (B). Efferocytosis of CFSE+ neutrophils by 
macrophages from WT and Galectin 3-/- mock control mice that received vehicle (M0 
PBS) or M. corti parasite (M2- M. corti) intraperitoneally. The bar graph (B’) indicates is 
the percent of Ly6G-F4/80+CFSE+ macrophages that have internalized CFSE labeled 
neutrophils calculated from 3 independent experiments that are shown in the 
representative density plots (B). (C). Macrophages from WT and Galectin 3-/- mock  
mice that received vehicle (M0-Mock) or IL4complex (M2- IL4c) by i.p. were analyzed 
for efferocytosis of CFSE labeled neutrophils. The bar graph (C’) indicates is the percent 
of Ly6G-F4/80+CFSE+ macrophages that have internalized CFSE labeled neutrophils 
calculated from 3 independent experiments that are shown in the representative density 









Figure II- S1. Peritoneal macrophage from WT mice exhibit M2-activation 
phenotype during M. corti i.p. infection.  
 
Peritoneal macrophages from mock control and M. corti i.p. infected mice were 
harvested, and the relative mRNA expression of M2 mediators, Arg1, PDL-2, MR-1, and 
M1 inflammatory mediators, NOS2 was measured by qRT-PCR.  























Figure S2. M2 macrophages extravasate into the CNS of WT and Galectin 3-/- mice at 
similar rate 
 
Purified bone marrow macrophages from WT mice differentiated to M2 activation by exposure to 
IL-4 in vitro, labeled with Carboxyfluorescein succinimidyl ester (CFSE) CellTracker Green, i.v. 
injected into WT or Galectin 3-/- recipient mice at 1wk i.c. infection with M. corti prior to injection. 
Twenty four hour post adoptive transfer brains were harvested and processed for flow cytometry to 














GALECTIN 7 ON ENDOTHELIAL CELLS IS INVOLVED IN ALTERNATELY 
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 M2 macrophages function to dampen host inflammatory responses and promote 
wound healing and tissue repair. As the blood-brain barrier (BBB) restricts the flow of both 
cells into the brain, understanding how M2 macrophages extravasate into the central 
nervous system (CNS) is of great interest. In a mouse model of neurocysticercosis (NCC) 
we previously demonstrated that M2 macrophages are essential in containing 
neuropathology in helminth-infected CNS. Analysis of helminth-infected mice revealed an 
abundant expression of Galectin 7 (Gal 7) that recognize galactose moieties in brain 
endothelial cells. The Galectin 7-/- NCC mice displayed a reduced accumulation of M2 
macrophage in the parasite-infected brain. This reduction in M2 macrophage numbers in 
the CNS was correlated with an increased neuropathology and shortened survival. The use 
of adoptive transfer of fluorescently labeled cells demonstrated a decreased influx of M2 
macrophage into the CNS of helminth-infected NCC brains. The use of in-vitro 
transmigration assay conclusively demonstrated a key function of Galectin 7 expressed on 





 The central nervous systems (CNS) is regarded as an immunologically privileged 
organ due to the absence of a classically defined lymphatic drainage system and the 
presence of the blood-brain barrier (BBB) that restricts the influx of blood-borne molecules 
and immune cells. However, when brain homeostasis is compromised as a result of 
challenges such as during infection, injury, or trauma, innate immune activation can lead 
to infiltration of various leukocytes to mount stimuli specific responses in the CNS 
microenvironment (116). In this regard, microglia and infiltrating macrophages function as 
the primary regulators of the innate immune-mediated development of inflammatory 
responses in the CNS (122-125). The functional phenotypes of macrophage/ microglia vary 
in response to external stimuli they receive through a wide variety of surface receptors (50). 
These cells with the M1, or classical activation phenotype, release multiple pro-
inflammatory molecules (51). M1-macrophages are critical effectors of inflammation and 
innate immunity as well as orchestrators of adaptive immunity to microbial infections (126, 
127). Whereas, macrophage/ microglia with M2, or alternatively activated phenotype, 
produces factors involved in anti-inflammatory and tissue remodeling functions (49, 53, 
54, 128). Interestingly, persistent M1 microglia/macrophages mediated pro-inflammatory 
mediators often have tissue destructive effects eventuating into severe neuropathological 
outcome in diseases affecting the CNS. In contrast, M2 phenotypes of these cells release 
numerous protective/trophic factors in vitro settings (129, 130). Because of the presumed 
ability of M2 cells to promote tissue repair/regeneration, transplantation of ex vivo 
activated M2 macrophages was used in clinical trial as a possible cell-based regenerative 
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strategy in spinal cord injury (131). Unfortunately, the phase II trial was not a complete 
success, and necessitating the requirement of further understanding of different aspect of 
M2 macrophage functions in the CNS. Use of pre-clinical models, where M2 macrophages 
play an important contributor to the CNS immunopathogenesis, could be vital to identify 
critical molecules responsible for their functions in brain. 
 The immune response during helminth parasitic infections predominantly involves 
M2 macrophages (132). Indeed, in a murine model of neurocysticercosis, due to intra-
cranial infection with a helminth Mesocestoides corti, the newly recruited macrophages 
display an M2 phenotype (40, 43, 58). Importantly, a lack of the M2 phenotype in 
macrophages was correlated with profound nervous tissue pathology and severe disease in 
STAT6-/- NCC mice (42). Interestingly, the M2 macrophages influx coincided with the 
release of glycan containing antigens from the tegument of the parasite in the CNS 
microenvironment (40). Furthermore, glycan antigens with terminal 
galactose/galactosamine are released from the parasite early and to larger extent. This 
raised the possibility of these antigens may induce glycan (with-terminal galactose)-
recognizing receptors to shape M2 macrophages trafficking into the CNS and the overall 
pathogenesis during brain parasitic infection. In this regard, the egress of leukocytes from 
the blood into tissues is tightly regulated and is mediated by a multistep process involving; 
leukocyte rolling, rapid activation of leukocyte, adhesion to endothelium, and diapedesis 
(117, 133). The interaction of leukocytes to the endothelium and successful transmigration 
involves different selectins that bind to specific carbohydrates, such as sialyl Lewis X 
(sLeX) on the endothelium or vice versa (117). Furthermore, studies show that C-type 
lectin receptors (CLRs) that bind to specific carbohydrates influence the outcome of 
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leukocyte accumulation in tissues by positively or negatively influencing leukocyte 
trafficking into the affected site (14). For example, CLRs such as MR1 and DC-SIGN have 
been observed to mediate cell trafficking across endothelium (134-138) whereas MGL and 
galectin 1 can inhibit migration of leukocytes through endothelium (137, 139). An 
important unanswered question, therefore, is whether specific lectin receptor/s are induced 
on brain endothelium during helminth infection to control M2 macrophage extravasation, 
which in turn play an essential role in the containment of this disease.  
 In this study, we identified that intracranial infection of mice with M. corti 
metacestodes results in upregulated expression of galectin 7 on brain endothelial cells. As 
galectin 7 expression was also upregulated in brain-derived endothelial cells in vitro after 
exposure to helminth factors or IL-4, the best-documented cytokines produced by the host 
in helminth infection. The susceptibility and immunopathology was compared between 
Galectin 7-/- and wild-type (WT) mice infected intra-cranially with M. corti. The 
contribution of galectin 7 to CNS inflammation was assessed by measuring infiltration of 
various immune cells into the brain, as well as pro-and anti-inflammatory mediators 
response in CNS of Galectin 7-/- and WT mice. By studying Galectin 7-/- and WT mice in 
vivo or brain-derived endothelial cells ex-vivo, for the first time, we demonstrate that 








Materials and Methods 
Mice and parasite inoculation.  
 Female mice age 4.5 to 6 weeks were used in this study. The C57BL/6 WT mice 
were purchased from Charles River Laboratories, Wilmington, MA. The Galectin 7-/- mice 
were kindly provided to us by Francoise Portier (Universite Paris Diderot, France). 
Mesocestoides corti (M. corti) was kindly provided by Dr. Debrosky Herbert (Cincinnati 
Children’s Research Foundation, Cincinnati, OH 45229, USA). M. corti metacestodes 
were maintained in the peritoneal cavity of BALB/c mice by serial intraperitoneal (i.P.) 
infection for propagation.  
 For intracranial infections, M. corti larvae were aseptically collected from the 
intraperitoneal cavity of the infected BALB/c mice and were extensively washed in HBSS. 
The metacestodes (about 60 parasites) were suspended in 50 µl of sterile HBSS and 
injected intracranially into 4.5 to 6 weeks old female mice using 1 ml syringes and a 25-
gauge needle. Control mice were given 50 µl of sterile HBSS. Priority to the inoculation, 
the mice were anesthetized with a mixture of xyline (120 µl /ml), ketamine (220 µl /ml) 
and PBS. 50 µl of the mixture was given to each mice.  
 At 1 week and 3 weeks, mice were anesthetized using isoflurane and perfused 
through the left ventricle with 20 ml of cold PBS.  
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Brain mononuclear cell isolation and Flow cytometry  
 The brain was instantly removed from perfused mice and leukocytes were 
processed for antibodies staining for flow cytometry analysis. Briefly, leukocytes single 
cells suspensions were isolated from parasite-infected brains of WT and Galectin 7-/- 
using percoll density gradient from GE healthcare (CAT# 17-0891-01). The cells were 
counted using trypan blue. 2x106 cells were pre-incubated with Fc blocker for 10min and 
then incubated with 50 µl of antibodies cocktail for 30 min. after incubation, the cells 
were washed 2 times with 500 µl FACS buffer (10% FBS in PBS) and the pellets were 
suspended in 350 µl of FACS buffer and analyzed on a BD LSRII flow cytometer (BD 
Biosciences).  
H&E Staining.  
 Parasite and HBSS infected brains were immediately removed from perfused WT 
and Galectin 7-/- mice, embedded in OCT resin and snap frozen. Serial horizontal cryo-
sections with 10 µm in thickness were positioned on slides (from Sigma-Aldrich, St. Louis, 
MO). Every 5th slides were sectioned and stain following the H&E staining protocol 
previously described.  
Adoptive transfer experiment 
 WT and Galectin 7-/- mice were intracranially infected with M. corti for 6 days. 
They were then adoptively transferred with labeled BMDM which were previously 
cultured with IL-4 (M2) or IFN-γ (M1). The M2 macrophages were labeled with cell trace 
CFSE (CAT# C34554, Thermo scientific Waltham, MA) and the M1 was labeled with Cell 
Trace Far-Red orange dye (CAT# C34564, Thermo scientific Waltham, MA).The cells 
labeled cells were a mix at 1:1 ratio and intravenously injected to the infected mice. via tail 
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vein injection. Brains were harvested 24 hrs after the tail vein injections, the infiltrating 
cells were collected and processed for flow cytometry as described above. Adoptively 
transferred macrophages recruited to the brains were enumerated using an LSR II flow 
cytometer and analyzed using FlowJo software (BD Biosciences, San Jose, CA).  
Endothelial cell’s isolation 
Mouse brain endothelial cells were isolated like it was described (140) and with the 
help of Dr. Abhay Sagare and Dr. Zlokovic V. Berislav with little modifications. Briefly, 
Brains were aseptically isolated for 8 weeks of WT and Galectin 7-/- mice using the 
MCDB31 medium (GIBCO BRL, New York) supplemented with 2% FBS, 100U/ml 
penicillin, and 100 µl/ml streptomycin. Meninges and big vessels were removed. The 
cortices were then cut into small pieces and homogenized using tissues Dounce 
homogenizer. The mixture was suspended in 15% dextran and centrifuged. The pellet was 
re-suspended in 0.1% collagenase/dispase made with 2% FBS medium. The mixture was 
incubated for 6hr at 37oC with sporadic agitation. After the incubation, the mixture was 
centrifuged at 1000Xg for 5 and the endothelial cells and microvessels found in the top 
layer were collected, centrifuged and plated in tissues culture plate coated with rat tail 
collagen I (Roche Diagnostics, Mannheim, Germany) and incubated at 37 with 5% C02. 
Every 2 days, the media was changed to enhance recovery. 
After few days of culture, the cells were collected using enzyme-free dissociation 
buffer and a magnetic purification step was used to reduce contamination. Briefly, the cells 
were incubated with rat CD31 primary antibody (1:50, BD Pharmagen, Lexington, KY) 
for 30 min at 4oC with gentle mixing. After incubation, cells were centrifuged and 
incubated with Dynabeads M-450 Sheep anti-rat for 20 min with shaking. The cells were 
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then washed and collated using magnet and plate on collagen I coated plate for father 
incubation. In addition, 70,000 cells were seeded in the insert with 8 µm pore (CAT# 
Corning) with media in the low chamber of the transwell. 
Trans-endothelial migration essay 
Once the cells had grown to appropriate confluency in the insert, FITC labeled 
dextran was used is a tie junction between the endothelial cells, 5µg/ml of dextran 
(3000MW, CAT#D3305 Thermo Fischer Scientific) was diluted in PBS and added to the 
endothelial cells. the concentration of dextran was measured in the low media using 
colorimeter. The cells were stimulated with Parasite derived molecules for 12 hrs. The 
lower media was changed with fresh media. Then the bone marrow-derived macrophages 
that were previously cultured with IL-4 to induce M2 phenotype were added to the upper 
chamber of the insert 5x105 macrophages were added with 500 µl of media. In order to 
mediate migration of the macrophages to the lower chamber, macrophages MCP-1 at 
100ng/ml was added to the media in the low chamber. After 24 hr of incubation, cells in 
the low chamber were counted.  
Immunofluorescence 
Immunofluorescence microscopy was used to determine the presence of immune 
mediators and/or specific cells types in brains of parasites infected and non-infected mice 
at various times post-infection 1wk. Brains from mock (HBSS infected) mice were used as 
controls and IF staining. All steps were carried out at room temperature. Briefly, the 
sections were incubated 10% host serum for 30 min, then with specific antibodies in PBS 
buffer with 3% host serum to prevent non-specific binding. After 40 min, the sections were 
washed seven times 3 min each in 50 mM Tris-HCl, pH 7.6 with 0.1% Tween-20 washing 
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buffer. The sections were then incubated with appropriate secondary antibodies for 30 min 
and were washed seven times with the above washing buffer. For double 
immunofluorescence staining, the above-mentioned procedures were sequentially repeated 
for each additional staining. The sections were mounted using Fluorsave reagent 
(Calbiochem, La Jolla, CA) containing 0.3 μM 4’, 6’-diamidino-2-phenylindole (DAPI)-
diacetate (Molecular Probes). Additional control staining was performed to rule out any 
nonspecific staining. In each case, sections were blocked with saturating concentrations of 
appropriate host serum antibodies to eliminate false positive staining due to FcR-mediated 
nonspecific binding. Staining in the absence of primary antibodies provided additional 
negative controls.  
In addition, IF microscopy in vitro settings using primary brain-derived endothelial 
cells (isolation described above) and bEnd.3 [BEND3] (ATCC, USA), a brain capillary 
endothelial cell line. Cells were pulsed with medium alone or exposed to helminth secreted/ 
soluble factors (HSF) or with IL-4. Bend.3 cells line ([Bend.3] (ATCCR CRL-2299TM). 
with specific antibodies in PBS buffer with 3% host serum to prevent non-specific binding. 
After 40 min, the sections were washed seven times 3 min each in 50 mM Tris-HCl, pH 
7.6 with 0.1% Tween-20 washing buffer. The sections were then incubated with 
appropriate secondary antibodies for 30 min and were washed seven times with the above 
washing buffer. For double immunofluorescence staining, the above-mentioned procedures 
were sequentially repeated for each additional staining. 
Antibodies and reagents  
All reagents were purchased from Sigma-Aldrich unless otherwise indicated. For 
detection of Galectin 7 by immunofluorescence (IF) staining, a purified rat anti-mouse 
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galectin 7 antibody clone 212923 (R&D system, Minneapolis, MN) followed by Alexa 546 
conjugated goat anti-rabbit antibody (Molecular Probes, OR) was used. A rat anti-mouse 
CD31 antibody conjugated to Alexa 488 (BD Pharmingen) were used for IF staining. A 
purified goat anti-mouse MGL1/2 (CAT# AF4297, R&D system, Minneapolis, MN) 
followed by donkey anti-goat Alexa 488/Alexa546 (Molecular Probes, OR). A purified 
goat anti-mouse MR-1 (CAT# AF2535, R&D system, Minneapolis, MN) followed by 
donkey anti-goat Alexa 488/Alexa546 (Molecular Probes, OR). For flow cytometry FITC 
anti-mouse CD11b (clone M1/70), PE-cy7 anti-mouse F4/80 (clone BM8), PE anti-mouse 
TCR γδ (clone GL-3), PE-cy7 anti-mouse siglec-f (clone FC50-2440), APC anti-mouse 
CD206 (clone C068C2), PE anti-mouse PD-L2 (T425), pacific blue anti-mouse CD45 
(clone 30-F11), and APC anti-mouse Ly6G (Clone 1A8) antibodies (Biolegend, San Diego, 
CA) were used. The terminal deoxyribonucleotidyl transferase-mediated triphosphate 
(dUTP)-biotin nick end labeling (TUNEL) staining kit was purchased from Chemicon 
International, CA. The endotoxin level was <1.0 EU per μg of protein. Ultrapure E. coli 
endotoxin was purchased from Invivogen and lactose was purchased from Sigma.  
Quantitative Real-Time PCR  
 Brain from infected and mock control WT and Galectin 7-/- mice 1 week and 3 
weeks post infection were directly perfused and the total RNA was extracted using trizol 
reagent (Invitrogen) according to the manufacturer’s instructions. Real-time PCR analysis 
of the samples was done using SYBRO green (Applied Biosystems, CA (USA). Transcript 
levels of the housekeeping ribosomal 18S and Galectin 7 genes were measured in each 
sample by PCR amplification using specific primers: 18S (sense) 5′- CAT GTG GTG TTG 
AGG AAA GCA-3’ and (antisense) 5′- GTC GTG GGT TCT GCA TGA TG-3′; galectin 
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7 (sense) 5’-GGC CAC TTT-GTT-GTA-TTG-3’ and ( antisense) 5’-GAC CAT GCC TCG 
AAT TCT CAT-3’ 
Statistical Analysis  
 The survival of the infected WT and Galectin 7-/-mice was compared using Log-
rank (Mantel-Cox) Test. The statistical comparison between levels of host mediators was 




Galectin 7 is abundantly expressed in brain endothelial cells during murine NCC  
To examine the role of galectin 7 in parasite-infected brains, its transcript-level of 
expression was determined by qRT-PCR using RNA from mock and M. corti i.c. infected 
brains. Increased mRNA expression (by ~ 2.5-fold) of galectin 7 was observed at 1wk p.i. 
over mock control at 1wk p.i. (Figure.III-1A). To identify the cell-specific expression of 
galectin 7 protein, in-situ co-immunostaining was performed on brain cryosections of mock 
control and parasite-infected mice. In mock-infected mice brains, galectin 7 was undetected 
(Figure.III-1B1). In contrast, parasite-infected brains exhibit an increased expression of 
galectin 7, which was primarily evident in periventricular and leptomeningeal areas of the 
NCC brain (Figure.III-1B1-B2). A unique extracellular matrix (ECM)-like fibrillar 
staining pattern for galectin 7 was observed (Figure.III-1B1-B2). Double IF staining on the 
parasite-infected brain sections showed large numbers of round monocyte/ macrophage-
like CD11B+ or F4/80+ cells extravasating through the pial vessels in meninges and 
detected in proximity of galectin 7 (Figure.III-1B3).  
The expression of galectin 7 on brain endothelial cells is unknown. To test the 
physiological relevance during helminth infections, the specificity of galectin 7 expression 
on brain endothelial cells was evaluated by IF microscopy in vitro settings using primary 
brain-derived endothelial cells as well as bEnd.3 [BEND3], a brain capillary endothelial 
cell line. Cells were pulsed with medium alone or exposed to helminth secreted/ soluble 
factors (HSF) or with IL-4. In this regard, IL-4 has been shown to be the critical cytokine 
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shaping many of the host response to helminth infections, including the signature M2 
phenotypic response by macrophage. Both bEnd.3 [BEND3], cells and primary brain 
endothelial cells exposed to HSF exhibited increased galectin 7 expression (Figure. III- 
1C). On the other hand, galectin 7 was undetected in the naïve/ unstimulated control cells 
cultured in presence of medium only (Figure. III-1C). Moreover, galectin 7 expression at 
protein level was detected at a massively higher level in IL-4 exposed bEND3 cells 
compared to the corresponding unstimulated naïve/ control cells (figure.III-1C). Together, 
the results confirmed that HSF and IL-4 stimulation induces an increased galectin 7 
expression, specifically in endothelial cells (CD31+) in vitro.  
Galectin 7-/- mice exhibit increased disease severity during murine NCC  
To investigate whether Galectin 7 influences host immunity to parasite infection of 
the brain, disease severity was compared between WT and Galectin 7-/- mice were infected 
i.c. with M. corti. As reported previously (141, 142), infected WT mice displayed typical 
neurological signs including abnormal vestibular function, tilted head, cerebral 
abnormalities, morbidity, and weight loss between 1-3wk p.i. In general, these overt signs 
appeared earlier and were more accentuated in Galectin 7-/- mice. In addition, Galectin 7-/- 
mice exhibited decreased survival. By 5wk p.i., only ~10% % of M. corti-infected WT 
mice succumbed to the infection as opposed to ~70% of Galectin 7-/- mice (Figure.III- 2A, 
p<0.0005). 
To determine the parasite burden, serial horizontal sections of parasite-infected WT 
and Galectin 7-/- brains of mice were stained with H&E, evaluated by microscopic analysis. 
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The brains of Galectin 7-/- mice exhibited increased numbers of parasites as compared to 
the infected brains of WT mice (Figure.III- 2B). Additionally, an increased numbers of M. 
corti was observed in brain parenchyma in Galectin 7-deficient mice, however, it was not 
statistically significant (Figure.III- 2B). Together, the results suggest that in the absence of 
galectin 7 dependent responses lead to an increased parasite growth in the CNS.  
 Next, H&E staining was performed to determine immunopathological changes in 
WT and Galectin 7-/- mice (Figure.III- 2C). Both the WT and Galectin 7-/- mice displayed 
normal brain tissue morphology. In contrast, a large number of infiltrating immune cells 
was detected in the CNS of both WT and Galectin 7-/- (Figure.III- 2C), albeit a somewhat 
lower number of infiltrating cells with morphology consistent with monocytes/ 
macrophages (round cells) was observed in the extra-parenchyma of parasite-infected 
Galectin 7-/- mice as compared to the WT (Figure.III-. 2C).  
To examine the impact of galectin 7 deficiency on the tissue pathology, TUNEL 
staining was performed on the brain tissue sections of WT and Galectin 7-/- mice. Very 
little to no TUNEL positive cells were detected in the CNS of mock of both WT and 
Galectin 7-/- mice (data not shown). Although the TUNEL staining remained low in the 
parasite-infected WT brains, the Galectin 7-/- mice displayed an increased TUNEL staining 
in the CNS (Figure.III- 2C). These data suggest that absence of galectin7 dependent 




Galectin 7-/- mice display decreased M2 macrophage accumulation in the CNS after 
parasite infection 
To determine the physiological relevance of galectin 7 on the infiltration of immune 
cells into the CNS during NCC, flow cytometry analysis was performed. Mononuclear cells 
from the whole brain of Galectin 7-/- and WT infected mice at 1wk p.i. The percent of 
macrophages (CD11b+F4/80+), neutrophils (CD11b+Ly6G+), eosinophils (Siglec-F+), γδ 
T cells (TCRδ+), αβ T cells (TCRβ+) or B cells (CD19+) were measured. No significant 
differences in the numbers of neutrophils, eosinophils, γδ T cells, αβ T cells or B cells at 
1wk p.i. in the CNS of parasite-infected Galectin 7-/- compared to the WT mice (Figure.III- 
3). However, infected Galectin 7-/- mice displayed significantly lower numbers of 
infiltrating macrophages in the CNS at 1wk p.i. Thus, these data demonstrate that absence 
of galectin 7 leads to a significant reduction in macrophage recruitment into the brain 
during NCC. 
Our previous studies have demonstrated that mice deficient in STAT6, an adaptor 
molecule contribute to the development of M2 macrophage phenotype (4), exhibit a lack 
of macrophages with M2 phenotype in the CNS correlated with increased pathological 
signs and severe mortality in NCC. To determine the effect of galectin 7 deficiency on the 
level of macrophages with M2 phenotype in the CNS during NCC, the expression of 
MGL1/2 (a cell surface marker specific for M2 cells) was analyzed in Galectin 7-/- mice by 
IF microscopy (Figure.III- 4A). Consistent with our previous findings, parasite-infected 
WT mice displayed an accumulation of large numbers of macrophages (CD11b+ cells) 
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with MGL1/2 (M2 activation phenotype) in the CNS at 1wk p.i. (Figure.III- 4A). In 
contrast, the parasite-infected Galectin 7-/- mice exhibited reduced accumulation of 
CD11b+MGL1/2+ M2 macrophages in the CNS (Figure.III- 4A). Taken together, the 
results here suggested that deficiency of galectin 7 is associated with a reduced influx of 
M2 macrophages in the CNS during NCC.  
Next, to determine if the infiltration of M2 macrophages is affected in the absence 
of galectin 7 flow-cytometric analysis was performed by staining the cells with anti-CD45, 
anti-F4/80, and PD-L2. It is important to note that CD45hiF4/80+ cells in the CNS are 
known to be infiltrating macrophages, whereas PD-L2 is a well-known marker of M2 
activation phenotype in macrophages (29, 45). Indeed, CD45hiF4/80+PD-L2+ M2 
macrophages were detected at significantly reduced numbers in the CNS of infected 
Galectin 7-/- mice at 1wk p.i. as compared to their WT counterparts (Figure.III- 4B). 
Together our data suggested that galectin 7 likely plays a role in the accumulation of M2 
macrophages in the CNS.  
Galectin 7 deficiency causes decreased M2 macrophages extravasation in vivo and in 
vitro 
 In order to confirm the role of galectin 7 in M2 macrophage recruitment into the 
CNS of NCC mice, we performed adoptive transfer of WT (Galectin 7+/+) M2- and M1- 
macrophage into WT and Galectin 7-/- mice (Figure.III- 5A, B). For this, naïve bone 
marrow-derived macrophages were polarized to M2- phenotype after exposure to IL-4, 
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whereas cells were stimulated with IFN-γ to drive their polarization to M1-functional 
phenotype (verified by expression of M1 activation marker NOS2) (data not shown). For 
adoptive transfer experiments, M1 and M2 macrophages were labeled with two different 
intracellular dyes (M1 cells with CFSE and M2 cells with CellTraceTM far-red dye). 
Injecting a mix of M1- and M2- types of macrophages and in equal numbers allowed us to 
compare the relative migration efficiency of these cells in the exact same 
microenvironment. The M. corti i.c. infected WT and Galectin 7-/- mice at 1wk p.i. received 
M1 or M2- macrophages by i.v. followed by flow cytometry analysis to measure CFSE+ 
cells and CellTraceTM+ cells after in the whole brain mononuclear cells. We observed that 
M2 macrophages were recruited in lesser numbers in parasite-infected brains of recipient 
Galectin 7-/- mice (Figure.III- 5B). However, no difference in the recruitment of M1-
macrophages was observed in recipient WT and Galectin 7-/- mice. (Figure.III-5B). 
Notably, i.v. injected M1 cells migrated with a lower relative efficiency compared to the 
M2 cells in the CNS microenvironment of the recipient parasite-infected WT and Galectin 
7-/- or WT mice. This is likely due to a CNS microenvironment, which is conducive for M2 
macrophage recruitment. Nonetheless, these results further solidified the fact that WT 
(Galectin 7+/+) M2- macrophages, but not the M1 macrophages, infiltration into the brain 
of Galectin 7-/- NCC mice is reduced. Next, transwell migration assay was performed to 
measures the capacity of M2 macrophages to transmigrate across a monolayer of brain-
derived endothelial cells from WT and Galectin 7-/- mice. Brain endothelial cells were 
isolated from both WT and Galectin 7-/- mice. Cells were cultured in a transwell insert to 
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form a monolayer as described in methods and by Dr. Zlokovic group (140). Cells were 
stimulated with helminth soluble/ secreted factors for 24h to induce galectin 7 expression. 
Bone marrow-derived macrophages that were polarized to M2- phenotype (described 
before), CFSE labeled, and 5x105 number of cells added to the upper chamber. The lower 
chamber contained media with 100ng/ml of MCP-1 chemoattractant for macrophages. 
Deficiency of galectin 7 on endothelial cells in upper chamber appear to affect M2-
macrophage trans-endothelial migration as evidenced by lower numbers of CFSE+ cells 
accumulated in the corresponding lower chamber (Figure.III- 5C). Together, the findings 
suggested a novel role of galectin 7 in specifically controlling M2 macrophages 
extravasation through brain en Galectin 7-/- NCC mice display reduced M2-macrophage 
associated anti-inflammatory/ immune mediators in the CNS  
  
 Galectin 7-/- mice display decreased M2- macrophage-associated anti-
inflammatory/ tissue protective mediators in the CNS after parasite infection 
 To determine a functional relevance of galectin 7 in the anti-inflammatory/ tissue 
protective response in parasite-infected CNS microenvironment, levels of multiple immune 
mediators e.g. cytokines, chemokines, and enzymes with tissue repair function, were 
compared in brain homogenates by CBA analysis and/ or RT-PCR analysis (Figure.III- 6). 
As compared to the mock animals the M. corti-infected WT and Galectin 7-/- mice brains 
exhibited increased levels of several inflammatory molecules, including key factors e.g. 
TNF-ᾳ, IL-1β, IL-12p70, IL-6, GM-CSF, IFN-γ, CXCL-9, -10, and NOS2, however there 
 
79 
were no statistically significant differences in their levels observed between infected 
Galectin 7-/- and WT mice (Figure.III- 6). On the other hand, significantly lower levels of 
anti-inflammatory factors (IL-13, IL-9, and especially the IL-10) were detected in the brain 
homogenates of parasite-inoculated Galectin 7-/- mice at 1wk p.i. compared to the WT. 
Moreover, the significance of galectin 7 was further corroborated with the RT-PCR 
analysis to measure the mRNA level of the factors directly involved in tissue regeneration/ 
repair such as YM1, Fizz1, and ARG-1. M. corti-infected brains of WT mice displayed a 
massive upregulated expression of these molecules (25 to several hundred-fold) over those 
in mock animals at both 1wk p.i. (Figure.III- 6B). In contrast, there was only a moderate 
increase in the mRNA level of these anti-inflammatory/ tissue protective factors in the CNS 
of parasite-infected Galectin 7-/- mice (Figure.III- 6B). Our results strongly suggest a 
decreased anti-inflammatory/ tissue protective response in the CNS of Galectin 7-/- mice 











 Increasing evidence supports an important role for M1 and M2 phenotype-specific 
roles of macrophages in multiple steps of CNS repair/regeneration (130). A switch from 
M1 to M2- phenotypic macrophages/ microglia facilitate diverse protective functions such 
as remyelination, oligodendrocyte renewal and white matter integrity, axonal regeneration, 
promote neurogenesis in models of multiple sclerosis to CNS injuries (143-145). On the 
other hand, a phenotype shift from M2-dominant to M1-dominant of macrophages at the 
site of injury impairs CNS repair (146-150). As most of the macrophages are recruited from 
the blood circulation to the CNS site in pathological settings, a better understanding of the 
mechanism of trafficking of these cells to the CNS is needed. It is also critical to identify 
how the macrophage trafficking regulator/s affect the anti-inflammatory/ tissue protective 
effect of these cells once inside the brain. Together, these could lead to the identification 
of novel therapeutic strategies to modulate macrophage function to promote CNS repair 
and/ or contain CNS pathology. Here we report that galectin 7, a host lectin receptor is 
upregulated specifically on the brain endothelial cells, and impacts the outcome of brain 
helminth infection as evidenced by a reduced survival, enhanced CNS pathology, because 
of decreased accumulation of M2- macrophages and associated immune mediators in the 
CNS of Galectin 7-/- mice. The use of in vitro transmigration assay as well as in vivo 
adoptive transfer experiments provided mechanistic basis of a key regulatory function of 
galectin 7 on endothelial cells in centrally regulating M2 macrophage entry into the CNS. 
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Our study shows, for the first time, a CNS protective role of galectin 7 by controlling M2 
macrophage influx into the helminth-infected brain.  
 
 After the infection of the CNS by M. corti during murine NCC, both parasites and 
immune cells are initially accumulated in extra parenchymal areas of the brain, which 
include ventricles, meninges and subarachnoid spaces (10, 30, 32, 39, 40). As the infection 
progresses, parasites and immune cells extravagate into the brain parenchyma typically 
depending upon the duration of infection (10, 30, 32, 39, 40). Macrophages represent the 
first type of immune cells to infiltrate into the brain (within first 3d p.i.) and are the 
predominant leukocyte populations throughout the infection process (4, 30). It was recently 
demonstrated that the initial release of galactose/ galactosamine containing glycan antigens 
by 1-2d p.i. precedes the accumulation of infiltrating macrophages with M2 activation 
phenotype. The early upregulated expression of galectin 7 on endothelial cells of the extra-
parenchymal CNS vasculature in the M. corti-infected WT brain, and in brain-derived 
endothelial cells after activation with helminth soluble/ secreted factors or IL-4 in vitro, 
suggest that galectin 7 may regulate the recruitment of immune cells into the brain. The 
severe reduction in M2 macrophages accumulation in the CNS of M. corti-infected 
Galectin 7-/- mice supports this idea. However, the early accumulation of all other immune 
cells were unaffected in Galectin 7-/- mice compared to their WT counterparts, indicating 
that Galectin 7 may be specifically involved in M2-macrophages influx only. Indeed, the 
adoptive transfer of both M1 and M2-macrophages of the WT origin demonstrated that 
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Galectin 7 was required only for the accumulation of M2-macrophages, but not M1-
macrophages, in the parasite-infected brains.  
 Our findings raised the fundamental question of whether the direct interaction 
galectin 7 on brain endothelial cells have with M2 macrophage facilitates regulates the M2 
cells trafficking. Alternatively, perhaps galectin 7 has an indirect role in this process by 
functioning as a PRR, whose activation leads to the induction of chemokines modulating 
M2 macrophages trafficking into the CNS. However, the expression of various key 
macrophage recruiting chemokines were unaffected in the CNS of Galectin 7-deficient 
mice following parasite infection. In case galectin 7 functioning as a PRR, we would expect 
to observe a decrease in macrophage chemoattractants in the CNS of Galectin 7-/- mice. 
Furthermore, we would expect the adoptively transferred M1 and M2 macrophages to reach 
the CNS of both WT and Galectin 7-/- NCC mice with similar frequency, which was not 
the case. On the other hand, in vitro transmigration assay settings, the extravasation of M2-
macrophages, but not M1-macrophages, was impaired through the monolayer brain-
derived endothelial cell from Galectin 7-/- mice compared to their WT counter parts. These 
results further highlight the likely critical function of the galectin 7 on brain endothelial 
cells directly interacting with the M2 macrophages and mediating their transmigration into 
the CNS during brain parasitic infection.  
Galectin 7 deficiency resulted in increased parasite burden both in the extra-
parenchyma and parenchyma of the brain. It is likely that reduced numbers of M2 
macrophages play a role in limiting parasite growth in the brain of Galectin 7-/- mice. This 
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is consistent with the results from our previous studies (4, 10) in murine NCC as well as 
from studies involving other parasite infections, a defect in Th2 dependent M2-
macrophages associated responses contribute to parasite growth correlated with increased 
disease severity in the host (151-153). Although a direct role of Galectin 7- mediated M2- 
macrophage accumulation and associated responses, contributing to disease severity was 
not established in the present study, the enhanced disease severity of Galectin 7-/- NCC 
mice was correlated with decreased IL-10 and IL-13 in the CNS as compared to WT mice. 
This indirectly indicates a possible protective role of galectin 7 through influencing M2-
macrophages trafficking in NCC. We are currently performing relevant adoptive transfer 
experiments to identify whether the transfer of WT M2 macrophages directly into the CNS 
of Galectin 7-/- NCC mice by i.c. injection with WT M2-macrophages would ameliorate 
the disease severity. The findings that galectin 7 on brain endothelial cells function as a 
central regulator in M2-macrophages influx into the CNS, and in its absence the reduced 
accumulation of M2 cells contribute to the lethality of Galectin 7-/- mice, may offer 












Figure III- 1.  Expression and distribution of galectin 7 in the parasite-infected 
brains and endothelial cells. 
 
Quantitative RT-PCR analysis and IF microscopy were performed on parasite-infected and mock 
control mice i.c. injected with helminth parasite M. corti and endothelial cells. (A) The total RNA 
was extracted from the brains at 1wk post inoculation and mRNA expression of galectin 7 was 
measured by qRT-PCR as described in Methods. The fold changes in parasite-infected brains were 
calculated over the levels in mock control mice using the formula 2−(ΔΔCt). Data shown are the mean 
± SEM of 3–4 mice per time point in two independent experiments. (B1-B2) Immunofluorescence 
staining was performed on brain tissue cryosections from mock or parasite- infected C57/BL6 mice. 
Nuclei (blue) were stained with 4’6’ diamidino-2-phenylindole-dilactate (DAPI). Galectin-7 was 
stained using an affinity purified anti-mouse galectin 7 goat IgG followed by Alexa Fluor® 546 
labeled (red) goat anti-rabbit IgG. (B3) Immunofluorescence staining was performed using purified 
anti-mouse galectin 7 and purified anti-mouse CD11B followed by Alexa Fluor® 488 labeled 
(Green). Images shown are representative of 3 independent experiments with 3–4 mice each. 
Magnification of 20X. (C) Immunofluorescence staining was performed brain Bend3 endothelial 
cells lines and primary endothelial cells pulsed with medium alone or exposed to helminth secreted/ 
soluble factors (HSF) or with IL-4. Nuclei (blue) were stained with 4’6’ diamidino-2-phenylindole-
dilactate (DAPI). Galectin 7 was stained using an affinity purified anti-mouse galectin 7 rat IgG 
followed by Alexa Fluor® 546 labeled (red) goat anti-rat IgG and CD31 was stained using an affinity 
purified anti-mouse CD31 rat IgG followed by Alexa Fluor 488 labeled (green). Images shown are 






Figure III- 2.  Galectin 7-/- mice exhibit reduced survival and increased brain 
pathology and parasite burden as the WT mice. 
 
(A) WT and Galectin 7-/- mice were i.c. infected with 60 M. corti and were assessed daily 
for disease severity. The survival was monitored for 3 weeks post inoculation. Statistical 
comparison of susceptibility was done by Log-rank (Mantel-Cox) Test, P<0.0005***, 
n=9-10. (B) Number of parasites at 1wk and 3wk p.i. in parenchymal (P) and extra 
parenchymal (EP) regions in individual Galectin 7-/- and WTbrains were calculated by 
microscopic examination of serial H&E-stained brain sections. The bars show average +/- 
SEM parasites from 5-6 mice per group. (C) Representative microscopic evaluation of 
H&E stained brain cryosections from WT and Galectin 7-/- mice i.c. injected with HBSS 
(mock) or with 60 parasites at indicated times p.i.. Magnification 200X. IF microscopy 
analysis was performed on brain cryosections from WT and Galectin 7-/- mice i.c. 
infected with 60 M. corti parasites to detect TUNEL positive staining (Red). Nuclei 
(blue) were stained with 4’6’ diamidino-2-phenylindole-dilactate (DAPI). Images are 







Figure III-3. Galectin 7-/- mice display decreased M2 macrophage accumulation in the 
CNS after parasite infection 
Brains were isolated from infected WT and Galectin 7-/- and infiltrating cells were 
isolated, stained and analyzed using flow cytometry. The cells were stained for 
different infiltrating cells. Each bar represents percent cells positive for individual 












Figure III- 5.  Parasite-infected Galectin 7-/- mice exhibit decreased M2 macrophages 
accumulation in brain. 
 
(A) Double immunofluorescence staining was performed on brain cryosections from WT 
and Galectin 7-/- mice i.c. injected with HBSS (mock) or with 60 parasites at 1wk .i.c. 
Macrophages (MGL-1+) were detected by using an affinity purified anti-mouse MGL-
1 goat IgG followed by Alexa Fluor® 546 labeled (red). CD11B was stained using 
purified CD11B goat IgG followed by Alexa Fluor® 488 labeled (green). Nuclei (blue) 
were stained with 4’6’ diamidino-2-phenylindole-dilactate (DAPI). Images shown are 
representative of 3 independent experiments with 3–4 mice each group. (B) Gating 
scheme to select C45hiF4/80+PD-L2 positive cells. Collected cells with gated with 
FSC and SCC singlet cells. The cells were then gating on CD45 and F4/80 and PD-L2 
positive cells. Representative FACS plots gated on CD45hi, F4/80+ and PD-L2+ 
(infiltrating M2 macrophages) from individual mouse brain showing cell surface 
expression of PD-L2. Results are representative of 3 independent experiments. ***P 








Figure III- 5. Galectin 7 expressing brain endothelial cells regulates M2 trafficking 
during NCC infection. 
 
(A) Schema of experimental procedure on adoptive transfer experiment as described in 
methods. (B) Purified bone marrow macrophages from WT mice were cultured with 
IFN-γ (M1) or Il-4 (M2). The M1 were labeled with CellTracker far-red and M2 with 
CellTracker Green CFSE. They mixed in 1:1 ratio and injected intravenously (i.v.) into 
WT or Galectin 7−/− recipient mice infected intracranially with M. corti 6 days prior 
to injection. Brains were harvested 24 hrs after the adoptive transfer and processed for 
flow cytometry. Data shown are mean ± SEM form 9 mice per group in 3 independent. 
Statistical significance are denoted by asterisks (*, p<0.05). (B). WT and Galectin 7 
brains endothelial cells were isolated and cultured in the upper layer invasion insert 
chamber. Upon, differentiation into endothelial cells, the cells were stimulated in the 
presence of parasite-derived molecules for 24hrs. BMDM were then incubated into 
the top of the chamber. CCL2 is added to the low chamber with media. After 24hrs, 
the number of cells that migrated into the lower compartment was counted using 
trypan blue. Results are representative of 2 independent experiments Statistical 





Figure III- 6.  Inflammatory mediators in the CNS of parasite-infected Galectin 7-/- . 
 
(A) The brains from mock control and M. corti infected WT and Galectin 7−/− mice 
were harvested at 1wk .i.c., homogenized, and the protein level of host immune 
mediators measured by CBA using flow cytometric analysis (BD Biosciences). 
Results shown are mean ± SEM of 3–4 each infected and mock control mice 
from 2–3 independent experiments. Statistical significances are denoted by 
asterisks (* p<0.05; ** p<0.005). (B) The total RNA was extracted from the 
brains at 1wk post inoculation and mRNA expressions of Arginase 1 (ARG 1), 
PD-L2, and YM-1 were measured by qRT-PCR as described in Methods. The 
fold changes in parasite-infected brains were calculated over the levels in mock 
control mice using the formula 2−(ΔΔCt). Data shown are the mean ± SEM of 3–
4 mice per time point in two independent experiments. Significant differences 
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 Helminth associated with parasitic infections are believed to release glycol-proteins 
which modulate the infections process. However, the specific receptors involved and their 
function during the parasitic infection, are yet to be completely determined. We examined 
the function of galectins, mammalian beta galactose-binding lectins, in a murine model for 
neurocysticercosis (NCC) induced by intracranial inoculation of the helminth parasite 
Mesocestoides corti. Parasite infection induced multiple galectins, among which Galectin 
9 was the first as to be upregulated as well as at a relatively high level in M2. Parasite-
infected Galectin 9-/- mice displayed significantly increased susceptibility to parasite 
infection, despite a similar parasite burden in the central nervous system (CNS) compared 
to infected wild-type (WT) mice. The accumulation of macrophages, γδ T cells, αβ T cells, 
or B cells in the brains of parasite-infected Galectin 9-/- mice was similar to the WT mice. 
Moreover, AAMs which play a profound protective role in murine NCC were observed an 
increased level in infected WT and Galectin 9-/- mice. Instead, the parasite-infected 
Galectin 9-/- mice exhibited a massive neutrophilia in the CNS and an increase in 
neutrophil-associated neuroinflammation. These results suggest that galectin 9 may be 
involved in controlling and resolving neutrophilia and inflammation, however, not by 
efferocytosis. For the first, we showed in the possible correlation between the presence of 
Galectin 9 and neutrophilia in NCC infection. Further experiments need to be done to 
determine the specific mechanism by which Galectin 9 is involved in this process.  




 Neurocysticercosis is a common central nervous system (CNS) parasitic disease 
caused by the presence of Taenia solium (9, 38). In humans, the infection manifests in a 
long asymptomatic phase where the parasite stays in the CNS as a cyst with no detectable 
inflammatory response detected surrounding the parasite (4, 11, 33, 40, 42, 43, 58). In 
contrast, virtually all the patients with symptomatic disease are characterized by prominent 
immunological responses in the brain (4, 58). Indeed, the severity of the symptoms is 
associated with the intensity of the immunological response in the CNS microenvironment 
(4, 40, 43, 58).  
 A mouse model of neurocysticercosis by infection with a related cestode 
Mesocestoides corti (M. corti), has been used to systematically characterize various aspects 
of the host-pathogen response during the entire infection process. In mice, the infection 
was found to associate with severe neurological manifestations. A predominant influx of 
immune cells consisting of macrophages and γδ T cells (3-5 days p.i), followed by αβ T 
cells (1wk p.i) and B-cells (3wk p.i) (141, 154), are differentially recruited into the brain 
after parasite inoculation. Furthermore, macrophages with M2-activation (alternative 
activation) phenotype of cells are thought to play an important immunological response to 
M. corti infection of the CNS as illustrated by the finding that mice deficient in STAT6 
exhibit severe CNS pathology with shorter time to death. Importantly, the degree of 
leukocyte accumulation in the CNS playing a critical role on neuropathology in the murine 
model parallels the results obtained with brain specimens from human patients (40), 
suggesting a key role of immune cells in the pathogenesis of the neurocysticercosis.  
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 Parasitic helminths (worms) in their pursuit to establish long-term infections and 
survival in the host use glycans which are abundant on their surface and in their 
excretory/secretory products (155, 156) to regulate and suppress host immune responses. 
In fact, more than 95% of NCC patients exhibit humoral responses against carbohydrate-
based antigens which are extensively used for immunodiagnosis of this disease. Indeed, 
glycan antigens from the tegument of T. solium and M. corti are found to be released in the 
CNS of humans and mice respectively (9, 157). Importantly, glycan antigens with terminal 
galactose are released from the parasites and are taken up by the host cells in the CNS 
environment in parasite-infected brains (60, 118, 158). Thus lectin receptors that recognize 
carbohydrates are likely to be critical in the subsequent immunological events and overall 
immunopathogenesis of NCC.  
 Galectins are important receptors involved in recognition of glycan structures, 
particularly containing terminal galactose, on a wide range of molecules in the host or from 
pathogens (26, 69-71, 74, 159). Indeed, galectins have been identified as key molecules 
that play important roles in cell proliferation, including neural progenitor cells, and 
contribute to tissue remodeling during experimental CNS injury (26, 69-71, 74, 160, 161). 
Members of galectins have been shown to play diverse roles such as in regulation of 
inflammation by sensing necrotic cells (162) or by exhibiting chemoattractant properties 
for leukocyte infiltration when secreted extracellularly (163, 164). Given the significant 
immunoregulatory role of galectins, the present study is focused on determining the role of 
galectin 9 on immunopathogenesis in mouse model of neurocysticercosis. The results 
indicate that both galectin 9 play a major role in controlling the initial influx of neutrophils 
into the CNS, and providing protection from brain parasite infection.  
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Materials and Methods  
Mice and parasite inoculation.  
 Female mice age 4.5 to 6 weeks were used in this study. The C57BL/6 mice were 
purchased by Charles River Laboratories, Wilmington, MA. Galectin 9-/- mice were 
purchased from Jackson Laboratories. Mesocestoides corti (M. corti) was kindly provided 
by Dr. Debrosky Herbert (Cincinnati Children’s Research Foundation, Cincinnati, OH 
45229, USA). M. corti metacestodes were maintained in the peritoneal cavity of BALB/c 
mice by serial intraperitoneal (i.P.) infection for propagation.  
 For intracranial infections, M. corti larvae were aseptically collected from the i.p. 
the cavity of the infected BALB/c mice and were extensively washed in HBSS. The 
metacestodes (about 60 parasites) were suspended in 50 µl of sterile HBSS and injected 
intracranially into 4.5 to 6 weeks old female mice using 1 ml syringes and a 25-gauge 
needle (10). Control mice were given 50 µl of sterile HBSS. Priority to the inoculation, the 
mice were anesthetized with a mixture of xylene (120 µl/ml), ketamine (220 µl/ml) and 
PBS. 50 µl of the mixture was given to each mice.  
 At 1 week and 3 weeks, mice were anesthetized using isoflurane and perfused 
through the left ventricle with 20 ml of cold PBS.  
Brain mononuclear cell isolation and Flow cytometry  
 The brain was instantly removed from perfused mice and leukocytes were 
processed for antibodies staining for flow cytometry analysis. Briefly, leukocytes single 
cells suspensions were isolated from parasite-infected brains of WT and Galectin 9-/- using 
percoll density gradient from GE healthcare (CAT# 17-0891-01). The cells were counted 
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using trypan blue. 2x106 cells were pre-incubated with Fc blocker for 10min and then 
incubated with 50 µl of antibodies cocktail for 30 min. after incubation, the cells were 
washed 2 times with 500 µl FACS buffer (10% FBS in PBS) and the pellets were suspended 
in 350 µl of FACS buffer and analyzed by BD LSRII flow cytometer (BD Biosciences).  
H&E and Immunofluorescence Staining.  
 Parasite and HBSS infected brains were immediately removed from perfused WT 
and Galectin 9-/- mice, embedded in OCT resin and snap frozen. Serial horizontal cryo-
sections with 10um in thickness were positioned on slides (from Sigma-Aldrich, St. Louis, 
MO). Every 5th slides were sectioned and stain following the H&E staining protocol 
previously described (42). Briefly, the slides were washed twice in deionized water, 
dehydrated for 30s in 100% ethanol, stained 30s in hematoxylin, and washed in distilled 
water for 2 min (42, 108). Tissue sections were stained with eosin for 15s followed by 2 
min treatment with 95 and 100% ethanol each. Slides were allowed to air dry, then 
submerged in xylene for 3 min, and mounted using the cytoseal mounting medium 
(Stephens Scientific, Riverdale, NJ). The number and location of parasites were determined 
by microscopic examination of the stained tissues. Tissues were also analyzed for the 
presence or absence of infiltrating leukocytes. 
 For IF microscopy, the frozen brain tissue sections were stained with relevant 
antibodies to detect immune parameters such as galectin 9, and immune cells (107). 
Briefly, brain tissue sections were incubated with specific primary antibodies in staining 
buffer (PBS buffer with 3% host serum) to prevent non-specific binding. After 45 min of 
incubations, sections were washed seven times 3 min each in 50 mM Tris-HCl, pH 7.6 with 
0.1% Tween-20 and incubated with appropriate secondary antibodies in staining buffer for 
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30 min. Sections were then washed seven times 3 min each in 50 mM Tris-HCl, pH 7.6 
with 0.1% Tween-20. For double IF staining, the above-mentioned procedures were 
sequentially repeated for each additional staining. The sections were mounted using 
FluorSave reagent (Calbiochem, La Jolla, CA) containing 0.3 μM 4’, 6’-diamidino-2-
phenylindole (DAPI)-diacetate (Molecular Probes). Additional control staining was 
performed to rule out any nonspecific staining. In each case, sections were blocked with 
saturating concentrations of appropriate host serum antibodies to eliminate false positive 
staining due to FcR-mediated nonspecific binding. Staining in the absence of primary 
antibodies provided additional negative controls. Primary and secondary antibodies used 
for IF staining are: Rabbit anti-galectin 9 (Abcam, San Diego, CA) and Alexa Fluor® 546 
or Alexa Fluor® 488 goat anti-rabbit (Molecular Probes, OR), Rat anti-mouse 7/4 
(Cedarlane, Burlington, NC) and Alexa Fluor® 546 or Alexa Fluor® 488 Goat anti-rat 
(Molecular Probes, OR), and Alexa Fluor® 546 or Alexa Fluor® 488 (Molecular Probes, 
OR). We evaluated tissue damage on frozen brain tissue sections from control and parasite-
infected brains by performing the terminal deoxyribonucleotidyl transferase-mediated 
triphosphate (dUTP)-biotin nick end labeling (TUNEL) staining as per manufacturer's 
instructions (Chemicon International, CA). In all the cases, the images were acquired using 
a Nikon eclipse 80i upright microscope (Nikon Corporation, Tokyo, Japan) with an 
attached cooled RTke Spot 7.3 three spot color camera (Diagnostic Instruments Inc., 
Sterling Heights, MI). The images were processed and analyzed using Adobe Photoshop 




 For these studies, peritoneal neutrophils were isolated from WT mice 12-16hr after 
intraperitoneal injection of sterile 4% thioglycollate (BD Biosciences, San Jose, CA) (46). 
For macrophages, WT and Galectin 9-/- mice were infected i.p. with M. corti (60-100 in 
numbers) and PECs were harvested after 4-5wk p.i. to collect M2 cells. Mock control mice 
instead received vehicle (PBS). On day-4 PECs were harvested to purify naïve 
macrophages for their role in this process. To obtain neutrophils, WT mice were injected 
i.p. with 4% thioglycollate for 16-18 hours.  
 The purity of the cells was ascertained by flow cytometry analysis (Ly6G+ 
neutrophils 80-85%; F4/80+ macrophages 85-90%). Isolated neutrophils were labeled with 
Carboxyfluorescein succinimidyl ester (CFSE; Cell Trace™ CFSE Cell Proliferation Kit 
from Invitrogen). Macrophages seeded on 6 well plates (1x106 cell/ml) were incubated 
with CFSE-labeled neutrophils at a ratio of 5:1(neutrophils: macrophages). After 2 hrs of 
efferocytosis, non-internalized neutrophils were removed by washing thoroughly. 
Macrophages were scraped and stained with F4/80 and Ly6G antibodies for flow 
cytometry. Gating scheme to quantitate Ly6G-F4/80+ CFSE+ efferocytic macrophages 
that had internalized labeled neutrophils is shown in Figure 8. For individual experiments, 
efferocytic index was calculated as percentage of Ly6G-F4/80+CFSE+ macrophages from 
WT and Galectin 9-/- mice that engulfed neutrophils (112). 
Quantitative Real-Time PCR  
 Brain from infected and mock control mice 1 week and 3 weeks post infection were 
directly perfused and the total RNA was extracted using trizol reagent (Invitrogen) 
according to the manufacturer’s instructions. Real-time PCR analysis of the samples was 
done using SYBRO green (Applied Biosystems, CA (USA). Transcript levels of the 
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housekeeping ribosomal 18S, Galectin 9.genes were measured in each sample by PCR 
amplification using specific primers.: removed 18S (forward) 5'-
CATGTGGTGTTGAGGAAAGCA-3' and (reverse) 5'-GTCGTGGGTTCTGCATGATG-
3'; Gal-9 (forward) 5'- TCAAGGTGATGGTGAACAAGAAA-3’ and (reverse) 5’- 
GATGGTGTCCACGAGGTGGTA -3’ 
Statistical Analysis  
 The survival of the infected WT and Galectin 9-/-mice was compared using Log-
rank (Mantel-Cox) Test. The statistical comparison between levels of host mediators was 
done with Student's t test using Sigma Plot 8. 
Results 
Predominant expression of galectin 9 in macrophages and astrocytes in the CNS after 
M. corti infection.  
Quantitative real-time PCR analysis was performed to determine the expression 
profile of galectins in mock-infected and parasite-infected brain. Upon infection, gene 
expression of several galectins was significantly upregulated. Among them, galectin 9 
mRNA expression was significantly upregulated at 1wk p.i. (~7-fold) and at 3wk p.i. (~3-
fold) (Figure.IV-1A). Next, in situ IF microscopy analyses were performed to determine 
the expression and distribution of galectin 9 at the protein level in brain tissues from mock-
infected control mice and in mice undergoing neurocysticercosis. In the uninfected 
animals, galectin 9 expression was largely undetected (Figure.IV-1B). At both 1wk and 
3wk p.i. approximately half of the immune cells present in meninges and ventricles were 
positive for galectin 9 protein (Figure.IV-1B). Double immunofluorescence analysis with 
anti-galectin 9 and antibodies to cell surface markers specific for various immune cells 
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indicated that the majority of cells detected positive for galectin 9 were CD11b positive 
myeloid cells detected in the intraparenchymal areas of CNS (Figure.IV-1B). 
Morphological, anatomical correlation, and colocalization staining strongly suggested that 
the upregulated galectin 9 at protein level was mainly detected in infiltrating myeloid cells. 
However, with the progression of infection time, some the astrocytes and their foot 
processes proximal to the pial vessels showed galectin 9 positive staining (data not shown).  
Galectin 9-/- mice are more susceptible to parasite infection in murine NCC  
 To investigate whether galectin 9 deficiency influences the overall immunity during 
the CNS infection with M. corti, disease severity was compared between WT and Galectin 
9-/- mice. The WT mice injected i.c. with M. corti displayed typical neurological signs 
including abnormal vestibular function, tilted head, cerebral abnormalities, morbidity, and 
weight loss between 1-3wk p.i. In general, these overt signs appeared earlier and were more 
accentuated in Galectin 9-/- mice. In addition, infected Galectin 9-/- mice exhibited 
decreased survival. By 7wk post-M. corti infection, 25% of M. corti-infected WT mice 
succumbed to the infection compared to 70% of Galectin 9-/- mice (Figure.IV- 2A, p<0.05).  
Galectin 9 deficiency has no effect on parasite load in infected  
To examine whether increased disease severity in galectin 9- deficient mice was 
associated with less effective control of parasite growth, serial horizontal sections of 
infected WT and Galectin 9-/- brains of mice were stained with H&E, and the number of 
M. corti metacestodes was determined by microscopic analysis. Both WT and Galectin 9-
/- mice exhibited similar numbers of parasites as compared to the infected brains of WT 
mice both early (1wk) and later (3wk) (Figure.IV- 2B) post-M. corti infection, suggesting 
 
100 
that galectin 9 dependenting responses have no influence on overall parasite growth in the 
CNS.  
Galectin 9-/- mice exhibit increased accumulation of neutrophils in parasite-infected 
brains 
Galectin 9-/- mice exhibited increased susceptibility to murine NCC. To investigate 
whether galectin 9 deficiency had any effect on immunopathological events, H&E staining 
was performed to determine immunopathological changes in WT and Galectin 9-/- mice at 
3wk p.i. (Figure.IV- 3A) depicts normal brain tissue morphology in WT and Galectin 9-/- 
control animals i.c. inoculated with HBSS. In contrast, a large number of infiltrating 
immune cells was observed in both parasite infected WT (Figure.IV-3A) and Galectin 9-/- 
mice (Figure.IV-3A). In parasite infected WT mice, a high proportion of infiltrating cells 
appeared to be myeloid (Figure.IV- 3B, inset), whereas in Galectin 9-/- mice the 
predominant cell type was polymorphonuclear cells (PMNs) (Figure.IV- 3A, inset). Next, 
using IF microscopy, the presence of neutrophils was analyzed at 3 wks after parasite 
inoculation. In wild-type mice, neutrophils (7/4+ cells) were scarcely detected in the brain 
at 3wk of parasite inoculation (Figure.IV- 3A). In contrast, the immune response revealed 
the presence of large numbers of 7/4+ neutrophils (Figure.IV- 3B) associated with the 
infiltrates in extra-parenchymal regions (ventricles, meninges, and subarachnoid spaces) at 
3wk p.i (Figure.IV- 3B). 
The flow-cytometry analysis was performed to quantify the differences in the levels 
of neutrophils recruited into the CNS of Galectin 9-/- and WT infected mice. The differences 
in recruitment of neutrophils in Galectin 9-/- mice were analyzed at both an early stage of 
infection (1 wk p.i.) and at the peak of inflammation (3 wk p.i.) (Figure.IV- 3C). M. corti 
 
101 
infection in both WT and Galectin 9-/- mice resulted in infiltration of similar numbers of 
CD11b+ly6G+ activated neutrophils at 1wk p.i. (Figure.IV- 3C). However, at 3wk p.i. 
infected Galectin 9-/- mice displayed significantly increased numbers of CD11b+Ly6G+ 
neutrophil cells as compared to the WT infected mice (Figure.IV- 3C). Thus, taken 
together, the histopathological and flow cytometric analyses demonstrate that absence of 
galectin 9 leads to a significant increase in neutrophils recruitment into the brain during 
NCC, particularly at the peak of inflammation.  
Inflammatory cytokines and chemokines expression in the CNS after M. corti 
infection.  
To determine whether Galectin 9-/- mice exhibit differences in immune mediators 
in the CNS during M. corti infection, the protein level of various cytokines, chemokines, 
and several other signature mediators were analyzed by CBA analysis. In infected Galectin 
9-/- mice, both IL-10 and IL-17 were detected at a lower level in the CNS at 1wk p.i., 
whereas a reduced IL-5 was detected in these mice at 3wk p.i. compared to the WT mice 
(Figure.IV- 4). To our surprise, in general, there were no significant differences between 
WT and Galectin 9-/- mice observed in the CNS levels of majority of the immune mediators 
analyzed (Figure.IV- 4). Moreover, the absence of galectin 9 did not appear to significantly 
influence the CNS level of neutrophil chemoattractants (CXCL1), neutrophil survival 
mediator (GM-CSF) in the parasite-infected- Galectin 9-/- mice as compared to the WT 
infected mice.  
Galectin 9-deficiency has no effect on efferocytic clearance of neutrophils.  
To determine the mechanism of neutrophils accumulation in the CNS of M. corti 
infected Galectin 9-/- mice, we examined the possible role of galectin 9 in neutrophil 
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clearance by efferocytosis. Macrophages from WT and Galectin 9-/- mice with or without 
infection with M .croti were exposed to CFSE–labeled dead neutrophils from WT mice in 
vitro. Flow-cytometric analysis was performed to measure the frequency of the Ly6G-
F4/80+CFSE+ cells, which represent the efferocytic macrophages that have internalized 
CFSE labeled neutrophils. The uptake of neutrophils by macrophages from Galectin 9-/- 
mice did not display any significant difference in comparison with the macrophage from 
WT mice. The results indicated that galectin 9 on macrophages does not participate in 
neutrophils clearance. Thus, a higher neutrophil accumulation in Galectin 9-/- brains is 
unlikely due to any defect in their efferocytic clearance by macrophages.  
Discussion  
Parasites express both nonhost-like and host-like glycan antigens (29). The 
expression of host-like glycans by parasitic helminths is widespread, and different host-
like glycans are found in a broad range of parasites (13, 91, 102, 118). It is thus no surprise 
that there is ever increasing evidence supporting a role for lectins, the glycan binding 
receptors, in immune functions. Because lectin receptors have been implicated in a wide 
variety of immunological functions including first-line defense against pathogens, cell 
trafficking, cell differentiation and immune regulation (26, 67, 71-73, 103, 165), a better 
understanding of their involvement in CNS immunopathogenesis might lead to the 
identification of novel therapeutic strategies against neuropathological conditions. Here we 
found that galactose-binding lectin galectin 9 is upregulated robustly within 7 days of 
infection in the CNS of mice infected i.c. with M. corti. We hypothesized that this early 
upregulation of galectin 9 is involved in providing necessary signals for regulating the 
immune responses in the CNS parasite-infected mice. Indeed, the results from present 
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studies strongly support the influence of galectin 9 on the host immune response affecting 
the pathogenesis of the CNS parasitic disease.  
Infection of the CNS by M. corti is characterized by the initial accumulation of 
parasites and inflammatory cells in extra-parenchymal areas of the brain, which include 
ventricles, meninges, and subarachnoid spaces. Macrophages represent the predominant 
leukocyte populations in the parasite-infected brain both initially and during prolonged 
infection (7, 81, 166, 167). In contrast, among the infiltrating immune cells, neutrophils 
are detected at a very low level both early and at later times of infection in the CNS during 
murine neurocysticercosis (33). To our surprise, we saw a larger accumulation of 
neutrophils in the CNS at the peak of inflammation (3wk p.i.) in M. corti-infected galectin 
9-deficient mice. Neutrophil-mediated responses are essential for combating microbial 
infection, however, their direct role in protection to helminth parasite infections is limited. 
Persistent accumulation of neutrophils can lead to bystander tissue destruction, owing to 
their noxious cargo (168). Thus, it is likely that the increased accumulation of neutrophils 
in the CNS of parasite-infected Galectin 9-/- mice is contributing to the exacerbated disease 
severity. Furthermore, the fact that most of the hyper-inflammatory mediators detected at 
similar level correlating with an unchanged parasite burden, further supports a direct effect 
of neutrophil-associated tissue damaging mediators contributing to the mortality of 
Galectin 9-/- mice. However, if galectin 9 absence eventuates in increased nervous tissue 
pathology in parasite-infected Galectin 9-/- mice remains to be determined.  
Accumulation of large numbers of neutrophils in the CNS microenvironment of 
parasite-infected Galectin 9-/- mice could either be due to modulation of expression of 
associated inflammatory mediators; due to a defect in their clearance by efferocytosis; or a 
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combination of both. Indeed, accumulating evidence suggests galectins can function as 
pattern recognition receptors (PRRs) in innate immunity as they bind both endogenous 
glycans as well as bind exogenous glycans on the surface of potentially pathogenic 
microbes, parasites, and fungi (50, 84). However, our findings strongly suggest galectin 9 
is unlikely functioning as a PRR in regulating neutrophil turnover in the CNS 
microenvironment. If galectin 9 is functioning as a PRR, we would expect to observe a 
significantly upregulated expression of chemokines and cytokines involved in neutrophil 
functions in the CNS of Galectin 9-/- mice. Instead, we found no significant difference in 
the level of neutrophil chemoattractants (CXCL1) and neutrophil survival mediators (GM-
CSF) in brain homogenates of parasite-infected WT and Galectin 9-/- mice. Moreover, IL-
17 was detected at a reduced level in the CNS of Galectin 9-/- mice at 3wk p.i. As IL-17 
activates pathway involved in neutrophils recruitment, our results further suggest an unlike 
role of Galectin 9 as a PRR, whose activation by parasite molecules controls the neutrophil 
recruitment. On the other hand, we also found no difference in efferocytic clearance of 
neutrophils by galectin 9 deficient macrophages from Galectin 9-/- mice inoculated with M. 
corti or PBS. In similar settings, deficiency of another related galectin, the galectin 3 on 
macrophages significantly decreases their capacity to efferocytosis neutrophils. Indeed, 
accumulation of large numbers of neutrophils in the brains of parasite-infected Galectin 3-
/- mice is due to a defect in efferocytic clearance of neutrophils by the galectin 3 deficient 
macrophages. In light of no observed role of galectin 9 as PRR or in efferocytosis, we are 
currently investigating a possible novel role of this lectin as a negative regulator of 
neutrophil influx into the CNS by performing adoptive transfer experiment. Relevant to 
our hypothesis, mouse MGL that binds galactose and galactosamine containing glycans, 
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has been reported to impede migration of immature dendritic cells (DCs) (112) as well as 
neutrophils (112). Indeed, MGL-1 has recently shown by us to negatively regulate 
neutrophils infiltration into the lungs of Klebsiella pneumonia infected mice (112). In toto, 
notwithstanding the mechanisms involved, this study shows that galectin 9 plays an 
important role in negatively regulating the neutrophil influx into the CNS, which can have 











Figure.IV- 1: Expression and distribution of galectin 9 in the parasite-infected 
brains  
(A) The total RNA was extracted from the brains at 1wk and 3wk post inoculation and 
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mRNA expression of galectin 9 was measured by qRT-PCR as described in Methods. 
The fold changes in parasite-infected brains were calculated over the levels in mock 
control mice using the formula 2−(ΔΔCt). Data shown are the mean ± SEM of 3–4 
mice per time point in two independent experiments. (B) Double immunofluorescence 
staining was performed on brain tissue cryosections from mock or parasite- infected 
C57/BL6 mice. Nuclei (blue) were stained with 4’6’ diamidino-2-phenylindole-
dilactate (DAPI). Galectin 9 was stained using an affinity purified anti-mouse galectin 
9 goat IgG followed by Alexa Fluor® 546 labeled (Red) Goat anti-Rabbit IgG. galectin 
9 expression was co-visualized with macrophages using an affinity purified anti-mouse 
CD11B Alexa Fluor® 488 labeled (Green). Images shown are representative of 3 








Figure.IV- 2: Galectin 9-/- mice exhibit reduced survival and increased brain 
pathology despite exhibiting similar parasite burden as the WT mice.  
 
(A) WT and Galectin 9-/- mice were i.c. infected with 60 M. corti and were assessed 
daily for disease severity. The survival was monitored for 3 weeks post inoculation. 
Statistical comparison of susceptibility was done by Log-rank (Mantel-Cox), 
P<0.05,n=9-10. (B) Number of parasites at 1wk and 3wk p.i. in parenchymal (P) and 
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extra parenchymal (EP) regions in individual Galectin 9-/- and WT brains were 
calculated by microscopic examination of serial H&E-stained brain sections. The bars 











Figure.IV- 3: Parasite-infected Galectin 9-/- mice exhibit increased neutrophil 
accumulation in brain.  
  
IF microscopy on brain cryosections from WT and Galectin 9-/- mice i.c. injected with 
HBSS (mock) or with 60 parasites at 1wk and 3wk p.i. Neutrophils (7/4+) were detected 
by using an affinity purified anti-mouse 7/4 goat IgG followed by Alexa Fluor® 546 
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labeled (red). Nuclei (blue) were stained with 4’6’ diamidino-2-phenylindole-dilactate 
(DAPI). Images shown are representative of 3 independent experiments with 3–4 mice 
each group. (B) Flow cytometry analysis of CD11b and Ly6G on brain mononuclear cells 
harvested from mock control and M. corti infected WT and Galectin 9-/- mice at 1wk and 
3wk p.i. The cells were double-stained with anti-Ly6G-APC and anti-CD11b-Pacific Blue 
antibodies as markers for neutrophils. Representative contour plots show CD11b+Ly6G+ 
neutrophils in brains of parasite-infected WT and Galectin 9-/- mice. The bar graph on 
the right shows mean ± SEM of percent of CD11b+Ly6G+ neutrophils in brains of M. corti 




Figure.IV- 4: Inflammatory mediators in the CNS of parasite-infected Galectin 9-/-  
and WT mice.  
 
(A) The brains from mock control and M. corti infected WT and Galectin 9-/- mice 
were harvested at 1wk and 3wk p.i., homogenized, and the protein level of host 
immune mediators measured by CBA using flow cytometric analysis (BD 
Biosciences). Results shown are mean ± SEM of 3–4 each infected and mock control 
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mice from 2–3 independent experiments. Statistical significances are denoted by 






Figure.IV- 5: Galectin 9-/- M2-macrophage do not exhibit defect in efferocytosis of 
neutrophils ex-vivo. 
 
 WT and Galectin 9-/- mice were either infected with M. corti , or PBS.( A) Efferocytosis 
of CFSE+ neutrophils by macrophages from WT and Galectin 9-/- mock control mice that 
received vehicle (M0-PBS) or M. corti parasite (M2- M. corti) intraperitoneally. The 
percent of Ly6G-F4/80+CFSE+ macrophages that have internalized CFSE labeled 









GENERAL DISCUSSION  
The major goal of these studies was to elucidate the protective correlates in NCC, focusing 
on mechanisms shaping trafficking of M2 macrophages into the CNS, and effector 
molecules expressed in M2 cells regulating CNS immunopathology. As in most other 
neuroinflammatory diseases, clinical presentations of NCC are thought to be influenced by 
chronic inflammatory responses causing neuropathology. In the absence of a classically 
defined lymphatic system in the CNS, macrophages and microglia functions as innate 
immune responders to infection. The initial recognition of microbial molecules by these 
cells induce the initial local inflammatory response and effector functions as well as 
shaping the subsequent pathogen-specific adaptive immune response. In this regard, it has 
been established that the M1 inflammatory functional phenotype in macrophages/ 
microglia generally promote the destruction of microbial pathogens, but also can cause 
widespread nervous tissue damage as well as impair CNS repair process (93). In contrast, 
emerging evidence suggests that M2 activation phenotype of these cells promote nervous 
tissue repair and restoration (95, 96, 99). However, direct mechanistic evidence showing 
the protective function of M2- macrophages/ microglia in the CNS microenvironment is 
limited. In addition, mechanisms specifically involved in M2 macrophage infiltration into 
the CNS is yet to be understood. In this regard, our work has shown before that in mouse 
model of NCC, M2 macrophages are first to infiltrate into the parasite-infected CNS. They 
seemed to play essential/ necessary roles in containing neuropathology and disease severity 
as the reduced number of cells with M2 activation phenotype in the CNS of STAT6-/- mice 
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was associated with heightened disease severity (none of the mice survived after 2wk p.i.). 
The objective of the proposed studies was to elucidate the M2 associated protective 
correlates in mouse model of NCC, focusing on; a) characterizing the mechanism/s 
regulating trafficking of M2 macrophages into the parasite-infected CNS, and b) effector 
molecules expressed in M2 cells regulating CNS immunopathology. In this regard, a 
growing body of evidence indicates that glycans from a number of pathogens including 
helminths act as PAMPs. Previous studies have shown that M. corti parasite infection is 
associated with the release of glycans in the CNS microenvironment. Particularly, the 
parasites release glycans containing terminal galactose/ galactosamine, both robustly and 
early during infection (40). In this study, we extended these findings and analyzed the 
expression and distribution of galectins, which are the most common PRRs that recognize 
galactose containing molecules, in normal and parasite-infected brains. We found a 
upregulate expression of galectin 3 and galectin 9 (infiltrating macrophages), and galectin 
7 (brain endothelial cells) in the parasite-infected brains. Our initial first hypothesis was 
that galectin 3 and galectin 9 expressed in M2 macrophages would contribute to the M2 
macrophages –mediated anti-inflammatory, immune-regulatory, and/ or tissue-protective 
responses to prevent the inflammation-induced pathology in parasite-infected brains. Our 
second hypothesis was that the parasite-infection induced expression of galectin 7 on brain 
endothelial cells would influence the trafficking of M2 macrophages into the CNS.  
 
 Although, galectin 3 have been detected in both immune cells, including dendritic 
cells, macrophages, and neutrophils (5, 50, 51, 53, 169) and nervous tissue cells such as 
microglia and astrocytes during different infection (57), in the helminth infected brains 
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galectin 3 was specifically detected in the cytosol of infiltrating M2 macrophages. Galectin 
3 has been demonstrated with diverse functions in host immunity. It acts both as PRRs to 
recognize pathogen structures but also can function by itself as a danger-associated 
molecular pattern (DAMP). It modulates the migration of immune cells to the sites of 
inflammation as well as augment the effector functions of these infiltrating immune cells. 
The diverse functions of galectin 3 thought to due to the difference in its cellular 
localization (extracellular, membrane-bound, or cytoplasmic), oligomerization, as well as 
the molecules it interacts with (72, 78, 103, 120). It has been shown to involve in bacterial 
clearance by macrophages (5) as well as modulating dendritic cells function to parasite 
infection (169). The importance of the galectin 3 in host immunity and pathogenesis is 
evident in several clinical settings. For example, infections of Galectin 3-/- mice in 
microbial infection involving Streptococcus pneumonia, H. pylori, and E. coli resulted in 
more severe disease outcome. Interestingly, the increased disease severity of Galectin 3-/- 
infected with Streptococcus pneumonia and H. pylori was due to the reduced neutrophil 
trafficking in the absence of galectin 3 contributing to an impairment of pathogen 
clearance. In contrast, we recently showed in F. novicida infection galectin 3 function as 
DAMP/ alarmin, and a reduced neutrophilic inflammation in Galectin 3-/- mice was 
correlated with reduced pathology and improved survival compared to the excessive 
inflammation associated sepsis signs in WT infected mice. Similarly, infection with 
Leishmania major, an intracellular parasite, an impaired neutrophil response and reduced 
inflammatory cytokine production contributes to an increase in parasite burden and 
susceptibility in Galectin 3-/- mice (170). In a model of a different parasitic infection, 
infection of mice with Toxoplasma gondii, galectin 3-deficient mice showed a reduced 
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inflammatory response with increased parasite burden in both systemic organs as well as 
in brain, correlated with an increased disease severity in them as compared to the infected 
WT mice (171). Thus, galectin 3 seems to play a role in promoting inflammation, including 
neutrophil-mediated response that improves survival to microscopic bacterial and parasitic 
infections. However, the results from our experiments demonstrated that deficiency of 
galectin 3 leads to increased accumulation of neutrophils and M2 macrophages in the 
helminth infected brains correlated with increased neuropathology and overall disease 
outcome. Importantly, the adoptive transfer of M2 macrophages from WT mice into 
Galectin 3-/- NCC mice reduced CNS inflammation in terms of decreased neutrophils 
accumulation, which coincided with lower infiltrating immune cell death. Thus, it is likely 
during infection with macroscopic helminth parasites, the abundant expression of galectin 
3 in M2 macrophages controls the neutrophilic accumulation. In the absence of galectin 3 
mediated function of M2 macrophages in reducing neutrophil accumulation leads to tissue 
pathology. Due to the sensitive nature of the nervous tissue, neutrophil-associated 
pathology in the absence of galectin 3 in M2 macrophages leads to severe clinical 
symptoms with fatal consequences in murine NCC.  
 One of the possibilities for the observed increased accumulation of neutrophils in 
the CNS of parasite-infected Galectin 3-/- mice could be due to a defect in efferocytosis of 
neutrophils by Galectin 3-/- M2 macrophages. This is somewhat supported by a recent study 
showing galectin 3 secreted by neutrophils facilitates efferocytosis of these cells by 
interacting with its ligand on macrophage surface (61). However, the data from our studies 
clearly suggested that galectin 3 in the cytosol of M2 macrophages regulates neutrophil 
turnover possibly by efferocytosis in the CNS microenvironment. In this regard, 
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efferocytosis is an important process by which phagocytic cells engulf and clear apoptotic 
cells (172-175). The multi-step efferocytosis process involves recognition of “find me” 
signals/ molecules presented by apoptotic cells. Some these “find me” molecules are ATP, 
UTP, CX3CL1, and lipid lysophosphatidylcholine (LPC), which allow the phagocytes cells 
to migrate towards the apoptotic cells. Some of the well-characterized receptors on 
macrophages such as P2Y2 receptor and G2A facilitates phagocytic cells interaction with 
these “Find me” signals (172-176). However, expression of “eat me” signals on the dying/ 
dead cells such as the phosphatidylserine (PS) by the phagocytic cells lead to uptake of the 
dying/ dead cells by phagocytes (172-176). In this regard, receptors such as Tim-3, Tim-4, 
as well as Stabilin 2 have been known to interact with the “eat me” ligands, and leading to 
the cytoskeleton rearrangement and internalization of the dying cells showed that Galectin 
3 plays a critical role in the clearance of dead neutrophils during NCC. Efferocytosis in 
critical to control inflammation. Although, the data from our studies clearly suggested a 
key role for galectin 3 in M2 macrophages associated efferocytosis, however, the 
mechanisms involved needs to be identified.  
 During murine NCC, similar to the galectin 3 expression profile, galectin 9 was 
primarily expressed in the infiltrating myeloid cells. We speculated that galectin 9 will 
function similarly as galectin 3 in regulating neutrophil turnover and associated 
inflammatory pathology. This was also supported by some of our recent works involving 
F. novicida intranasal infection, where both galectin 3 and galectin 9 found to function as 
alarmins and mice deficient of either galectin 3 or galectin 9 intra-nasally infected with F. 
novicida, displayed reduced neutrophil accumulation and tissue pathology in the lungs 
(107, 177). This was correlated with a decreased systemic inflammation and improved 
 
115 
survival in Galectin 3-/- and Galectin 9-/- mice. Similar to our findings in Galectin 3-/- NCC 
mice discussed above, an increased accumulation of neutrophils in the CNS of parasite-
infected Galectin 9-/- mice, albeit the effect was relatively less pronounced as compared to 
that observed with galectin 3 deficiency. Moreover, infected Galectin 9-/- mice displayed 
higher neuropathology and increased susceptibility to M. corti infection of the CNS. 
Mechanistically, however, in contrast to the role of galectin 3 in M2-macrophage mediated 
efferocytosis, M2 macrophages from Galectin 9-/- mice displayed no defect in efferocytosis 
of neutrophils. Notwithstanding the mechanisms involved, galectin 9 promotes anti-
inflammatory/ immune-regulatory role by controlling neutrophils turnover in the parasite-
infected CNS to prevent the inflammation-induced pathology. Perhaps, Galectin 9 by 
binding to its ligand Tim-3 or CD44 facilitates apoptotic clearance of neutrophils as 
observed for galectin 9 mediated immune cell clearance reported in other pathological 
settings (8, 63). Indeed, neutrophils express both CD44 and Tim-3 on their surface. Another 
possibility is that galectin 9 presence on neutrophil surface regulates its turnover and 
thereby contributing to the observed disease severity in galectin 9-deficient mice.  
A considerable body of evidence supports the view that microglia/macrophages are potent 
modulators of the outcome of neuropathological conditions such as in brain infections, 
stroke, traumatic brain injury, and spinal cord injury (5, 6). For instance, M2 macrophage/ 
microglia-induced response is thought to be important in nervous tissue repair as well as 
containment of neuropathology. However, most of our knowledge of these important 
findings are derived from in vitro studies or in vivo studies where M2 cells are depleted 
using chemicals. Here using a murine model of NCC, we further provided direct 
mechanistic evidence showing the protective function of M2- macrophages to decrease 
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neuropathology and improved mortality during CNS helminth infection. Galectin 7 plays 
an important role in initial influx of M2 macrophages into the CNS as indicated by reduced 
numbers of these cells observed in the CNS microenvironment of the parasite-infected 
Galectin 7-/- mice. Importantly, adoptive transfer of galectin 7+/+ (WT) M2 macrophages 
failed to migrate into the CNS of parasite-infected galectin 7-deficient mice further 
indicating galectin 7 as a central regulator of M2 cells transmigration into the CNS. The 
findings suggests that galectin 7 on brain endothelial cells a critical role in regulating M2-
macrophages influx into the CNS, and in its absence the reduced accumulation of M2 cells 
contribute to the lethality of Galectin 7-/- mice, may offer important mechanisms to target 
in CNS inflammatory disease conditions. On the other hand, galectin 3 and galectin 9 
upregulation were found predominantly in infiltrating macrophages and infiltrating 
myeloid cells respectively. As an increased neutrophilia was observed in the CNS of 
Galectin 3-/- and Galectin 9 mice, suggesting they play immune regulatory functions in the 
CNS microenvironment. In toto, our studies make an important contribution in establishing 
the novel protective mechanisms of M2 macrophages functions in the CNS pathological 
conditions. Our studies provide a better understanding of the immunopathogenesis of NCC 













Figure.V: Working model 
 
Murine NCC are believed to release parasitic glycans in the CNS microenvironment. The 
glycans induce the differential expression of galectins that recognize galactose moieties, in 
endothelial cells play a critical role in immunopathology by modulating trafficking of M2 
macrophages into the CNS, whereas galectins expressed in M2 cells controls the protective 
functions of these cell types including Nervous tissue repair, preventing NCS pathology 
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69. Römer CE, Elling L. 2011. Galectins: Structures, binding properties and function 
in cell adhesion, Biomaterials-Physics and Chemistry. InTech. 
70. Vasta GR. 2009. Roles of galectins in infection. Nat Rev Microbiol 7:424-38. 
71. Vasta GR, Ahmed H, Nita-Lazar M, Banerjee A, Pasek M, Shridhar S, Guha P, 
Fernandez-Robledo JA. 2012. Galectins as self/non-self recognition receptors in 
innate and adaptive immunity: an unresolved paradox. Front Immunol 3:199. 
72. D'Haene N, Maris C, Rorive S, Decaestecker C, Le Mercier M, Salmon I. 2014. 
Galectins and neovascularization in central nervous system tumors. Glycobiology 
24:892-8. 
73. Leffler H, Carlsson S, Hedlund M, Qian Y, Poirier F. 2002. Introduction to 
galectins. Glycoconj J 19:433-40. 
74. Rabinovich GA, Baum LG, Tinari N, Paganelli R, Natoli C, Liu FT, Iacobelli S. 
2002. Galectins and their ligands: amplifiers, silencers or tuners of the 
inflammatory response? Trends Immunol 23:313-20. 
75. Sato S, St-Pierre C, Bhaumik P, Nieminen J. 2009. Galectins in innate immunity: 
dual functions of host soluble beta-galactoside-binding lectins as damage-
associated molecular patterns (DAMPs) and as receptors for pathogen-associated 
molecular patterns (PAMPs). Immunol Rev 230:172-87. 
76. Cummings RD. 2014. T cells are Smad'ly in love with galectin-9. Immunity 
41:171-3. 
77. Steelman AJ, Li J. 2014. Astrocyte galectin-9 potentiates microglial TNF 
secretion. J Neuroinflammation 11:144. 
78. Breuilh L, Vanhoutte F, Fontaine J, van Stijn CM, Tillie-Leblond I, Capron M, 
Faveeuw C, Jouault T, van Die I, Gosset P, Trottein F. 2007. Galectin-3 
modulates immune and inflammatory responses during helminthic infection: 
impact of galectin-3 deficiency on the functions of dendritic cells. Infect Immun 
75:5148-57. 
79. Park D, Tosello-Trampont AC, Elliott MR, Lu M, Haney LB, Ma Z, Klibanov 
AL, Mandell JW, Ravichandran KS. 2007. BAI1 is an engulfment receptor for 
apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature 450:430-4. 
80. Lalancette-Hebert M, Swarup V, Beaulieu JM, Bohacek I, Abdelhamid E, Weng 
YC, Sato S, Kriz J. 2012. Galectin-3 is required for resident microglia activation 
and proliferation in response to ischemic injury. J Neurosci 32:10383-95. 
 
123 
81. Jouault T, El Abed-El Behi M, Martinez-Esparza M, Breuilh L, Trinel PA, 
Chamaillard M, Trottein F, Poulain D. 2006. Specific Recognition of Candida 
albicans by Macrophages Requires Galectin-3 to Discriminate Saccharomyces 
cerevisiae and Needs Association with TLR2 for Signaling. The Journal of 
Immunology 177:4679-4687. 
82. Wright RD, Souza PR, Flak MB, Thedchanamoorthy P, Norling LV, Cooper D. 
2017. Galectin-3-null mice display defective neutrophil clearance during acute 
inflammation. J Leukoc Biol 101:717-726. 
83. Biron-Pain K, Grosset AA, Poirier F, Gaboury L, St-Pierre Y. Expression and 
functions of galectin-7 in human and murine melanomas. PLoS One 8:e63307. 
84. Demers M, Magnaldo T, St-Pierre Y. 2005. A novel function for galectin-7: 
promoting tumorigenesis by up-regulating MMP-9 gene expression. Cancer Res 
65:5205-10. 
85. Saussez S, Kiss R. 2006. Galectin-7. Cellular and molecular life sciences 63:686-
697. 
86. Wu C, Thalhamer T, Franca RF, Xiao S, Wang C, Hotta C, Zhu C, Hirashima M, 
Anderson AC, Kuchroo VK. 2014. Galectin-9-CD44 interaction enhances 
stability and function of adaptive regulatory T cells. Immunity 41:270-82. 
87. Ransohoff RM. 2016. How neuroinflammation contributes to neurodegeneration. 
Science 353:777-83. 
88. An C, Shi Y, Li P, Hu X, Gan Y, Stetler RA, Leak RK, Gao Y, Sun BL, Zheng P, 
Chen J. 2014. Molecular dialogs between the ischemic brain and the peripheral 
immune system: dualistic roles in injury and repair. Prog Neurobiol 115:6-24. 
89. Gadani SP, Walsh JT, Lukens JR, Kipnis J. 2015. Dealing with Danger in the 
CNS: The Response of the Immune System to Injury. Neuron 87:47-62. 
90. Hu X, Leak RK, Shi Y, Suenaga J, Gao Y, Zheng P, Chen J. 2015. Microglial and 
macrophage polarization-new prospects for brain repair. Nat Rev Neurol 11:56-
64. 
91. Girgis NM, Gundra UM, Loke P. 2013. Immune regulation during helminth 
infections. PLoS Pathog 9:e1003250. 
92. Gundra UM, Girgis NM, Ruckerl D, Jenkins S, Ward LN, Kurtz ZD, Wiens KE, 
Tang MS, Basu-Roy U, Mansukhani A, Allen JE, Loke P. 2014. Alternatively 
activated macrophages derived from monocytes and tissue macrophages are 
phenotypically and functionally distinct. Blood 123:e110-22. 
93. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. 2010. Mechanisms 
underlying inflammation in neurodegeneration. Cell 140:918-934. 
94. Nakagawa Y, Chiba K. 2015. Diversity and plasticity of microglial cells in 
psychiatric and neurological disorders. Pharmacol Ther 154:21-35. 
95. Franco R, Fernandez-Suarez D. 2015. Alternatively activated microglia and 
macrophages in the central nervous system. Prog Neurobiol 131:65-86. 
96. Hu X, Li P, Guo Y, Wang H, Leak RK, Chen S, Gao Y, Chen J. 2012. 
Microglia/macrophage polarization dynamics reveal novel mechanism of injury 
expansion after focal cerebral ischemia. Stroke 43:3063-70. 
97. David S, Kroner A. 2011. Repertoire of microglial and macrophage responses 
after spinal cord injury. Nat Rev Neurosci 12:388-99. 
 
124 
98. Mosser DM, Edwards JP. 2008. Exploring the full spectrum of macrophage 
activation. Nat Rev Immunol 8:958-69. 
99. Miron VE, Boyd A, Zhao JW, Yuen TJ, Ruckh JM, Shadrach JL, van 
Wijngaarden P, Wagers AJ, Williams A, Franklin RJM, Ffrench-Constant C. 
2013. M2 microglia and macrophages drive oligodendrocyte differentiation 
during CNS remyelination. Nat Neurosci 16:1211-1218. 
100. Mahanty S, Garcia HH, Cysticercosis Working Group in P. 2010. Cysticercosis 
and neurocysticercosis as pathogens affecting the nervous system. Prog Neurobiol 
91:172-84. 
101. Nash TE, Garcia HH. 2011. Diagnosis and treatment of neurocysticercosis. Nat 
Rev Neurol 7:584-94. 
102. Dell A, Haslam SM, Morris HR, Khoo K-H. 1999. Immunogenic glycoconjugates 
implicated in parasitic nematode diseases. Biochimica et Biophysica Acta (BBA)-
Molecular Basis of Disease 1455:353-362. 
103. Cooper D, Iqbal AJ, Gittens BR, Cervone C, Perretti M. 2012. The effect of 
galectins on leukocyte trafficking in inflammation: sweet or sour? Ann N Y Acad 
Sci 1253:181-92. 
104. Cooper DN. 2002. Galectinomics: finding themes in complexity. Biochim 
Biophys Acta 1572:209-31. 
105. MacKinnon AC, Farnworth SL, Hodkinson PS, Henderson NC, Atkinson KM, 
Leffler H, Nilsson UJ, Haslett C, Forbes SJ, Sethi T. 2008. Regulation of 
alternative macrophage activation by galectin-3. J Immunol 180:2650-8. 
106. Ivashkiv LB. 2013. Epigenetic regulation of macrophage polarization and 
function. Trends Immunol 34:216-23. 
107. Mishra BB, Li Q, Steichen AL, Binstock BJ, Metzger DW, Teale JM, Sharma J. 
2013. Galectin-3 functions as an alarmin: pathogenic role for sepsis development 
in murine respiratory tularemia. PloS one 8:e59616. 
108. Mishra BB, Mishra PK, Teale JM. 2006. Expression and distribution of Toll-like 
receptors in the brain during murine neurocysticercosis. J Neuroimmunol 181:46-
56. 
109. Sun Y, Chauhan A, Sukumaran P, Sharma J, Singh BB, Mishra BB. 2014. 
Inhibition of store-operated calcium entry in microglia by helminth factors: 
implications for immune suppression in neurocysticercosis. J Neuroinflammation 
11:210. 
110. Gundra UM, Girgis NM, Gonzalez MA, San Tang M, Van Der Zande HJP, Lin 
JD, Ouimet M, Ma LJ, Poles J, Vozhilla N, Fisher EA, Moore KJ, Loke P. 2017. 
Vitamin A mediates conversion of monocyte-derived macrophages into tissue-
resident macrophages during alternative activation. Nat Immunol 18:642-653. 
111. Girgis NM, Gundra UM, Ward LN, Cabrera M, Frevert U, Loke P. 2014. 
Ly6C(high) monocytes become alternatively activated macrophages in 
schistosome granulomas with help from CD4+ cells. PLoS Pathog 10:e1004080. 
112. Jondle CN, Sharma A, Simonson TJ, Larson B, Mishra BB, Sharma J. 2016. 
Macrophage Galactose-Type Lectin-1 Deficiency Is Associated with Increased 




113. Bystrom J, Evans I, Newson J, Stables M, Toor I, van Rooijen N, Crawford M, 
Colville-Nash P, Farrow S, Gilroy DW. 2008. Resolution-phase macrophages 
possess a unique inflammatory phenotype that is controlled by cAMP. Blood 
112:4117-27. 
114. Fernandez-Boyanapalli R, Frasch SC, Riches DW, Vandivier RW, Henson PM, 
Bratton DL. 2010. PPARgamma activation normalizes resolution of acute sterile 
inflammation in murine chronic granulomatous disease. Blood 116:4512-22. 
115. Wang G, Zhang J, Hu X, Zhang L, Mao L, Jiang X, Liou AK, Leak RK, Gao Y, 
Chen J. 2013. Microglia/macrophage polarization dynamics in white matter after 
traumatic brain injury. J Cereb Blood Flow Metab 33:1864-74. 
116. Ransohoff RM, Kivisakk P, Kidd G. 2003. Three or more routes for leukocyte 
migration into the central nervous system. Nat Rev Immunol 3:569-81. 
117. Shi C, Pamer EG. 2011. Monocyte recruitment during infection and 
inflammation. Nature reviews Immunology 11:762. 
118. Sperandio M, Gleissner CA, Ley K. 2009. Glycosylation in immune cell 
trafficking. Immunol Rev 230:97-113. 
119. Ge XN, Ha SG, Liu FT, Rao SP, Sriramarao P. 2013. Eosinophil-expressed 
galectin-3 regulates cell trafficking and migration. Front Pharmacol 4:37. 
120. Jia W, Kidoya H, Yamakawa D, Naito H, Takakura N. 2013. Galectin-3 
accelerates M2 macrophage infiltration and angiogenesis in tumors. Am J Pathol 
182:1821-31. 
121. Nash TE, Singh G, White AC, Rajshekhar V, Loeb JA, Proano JV, Takayanagui 
OM, Gonzalez AE, Butman JA, DeGiorgio C, Del Brutto OH, Delgado-Escueta 
A, Evans CA, Gilman RH, Martinez SM, Medina MT, Pretell EJ, Teale J, Garcia 
HH. 2006. Treatment of neurocysticercosis: current status and future research 
needs. Neurology 67:1120-7. 
122. Rivest S. 2009. Regulation of innate immune responses in the brain. Nature 
Reviews Immunology 9:429-439. 
123. Cherry JD, Olschowka JA, O’Banion MK. 2014. Neuroinflammation and M2 
microglia: the good, the bad, and the inflamed. Journal of neuroinflammation 
11:98. 
124. Ramesh G, MacLean AG, Philipp MT. 2013. Cytokines and chemokines at the 
crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. 
Mediators of inflammation 2013. 
125. Kielian M. 2014. Mechanisms of virus membrane fusion proteins. Annual review 
of virology 1:171-189. 
126. Glass CK, Natoli G. 2016. Molecular control of activation and priming in 
macrophages. Nature immunology 17:26-33. 
127. Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M. 2013. Macrophage 
plasticity and polarization in tissue repair and remodelling. The Journal of 
pathology 229:176-185. 
128. Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, Gordon S, 
Hamilton JA, Ivashkiv LB, Lawrence T. 2014. Macrophage activation and 
polarization: nomenclature and experimental guidelines. Immunity 41:14-20. 
129. Mosser DM, Edwards JP. 2008. Exploring the full spectrum of macrophage 
activation. Nature reviews immunology 8:958-969. 
 
126 
130. David S, Kroner A. 2011. Repertoire of microglial and macrophage responses 
after spinal cord injury. Nature Reviews Neuroscience 12:388-399. 
131. Lammertse D, Jones L, Charlifue S, Kirshblum S, Apple D, Ragnarsson K, Falci 
S, Heary R, Choudhri T, Jenkins A. 2012. Autologous incubated macrophage 
therapy in acute, complete spinal cord injury: results of the phase 2 randomized 
controlled multicenter trial. Spinal cord 50:661-671. 
132. Kreider T, Anthony RM, Urban JF, Gause WC. 2007. Alternatively activated 
macrophages in helminth infections. Current opinion in immunology 19:448-453. 
133. Springer TA. 1994. Traffic signals for lymphocyte recirculation and leukocyte 
emigration: the multistep paradigm. Cell 76:301-314. 
134. Sturge J, Todd SK, Kogianni G, McCarthy A, Isacke CM. 2007. Mannose 
receptor regulation of macrophage cell migration. Journal of leukocyte biology 
82:585-593. 
135. Nieminen J, St-Pierre C, Bhaumik P, Poirier F, Sato S. 2008. Role of galectin-3 in 
leukocyte recruitment in a murine model of lung infection by Streptococcus 
pneumoniae. The Journal of Immunology 180:2466-2473. 
136. Fukumori T, Takenaka Y, Yoshii T, Kim H-RC, Hogan V, Inohara H, Kagawa S, 
Raz A. 2003. CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. 
Cancer research 63:8302-8311. 
137. Cooper D, Norling LV, Perretti M. 2008. Novel insights into the inhibitory effects 
of Galectin-1 on neutrophil recruitment under flow. Journal of leukocyte biology 
83:1459-1466. 
138. Van Kooyk Y, Geijtenbeek TB. 2002. A novel adhesion pathway that regulates 
dendritic cell trafficking and T cell interactions. Immunological reviews 186:47-
56. 
139. van Vliet SJ, Paessens LC, Broks-van den Berg VC, Geijtenbeek TB, van Kooyk 
Y. 2008. The C-type lectin macrophage galactose-type lectin impedes migration 
of immature APCs. The Journal of Immunology 181:3148-3155. 
140. Wu Z, Hofman FM, Zlokovic BV. 2003. A simple method for isolation and 
characterization of mouse brain microvascular endothelial cells. Journal of 
neuroscience methods 130:53-63. 
141. Cardona AE, Restrepo BI, Jaramillo JM, Teale JM. 1999. Development of an 
animal model for neurocysticercosis: immune response in the central nervous 
system is characterized by a predominance of gamma delta T cells. J Immunol 
162:995-1002. 
142. Cardona AE, Teale JM. 2002. Gamma/delta T cell-deficient mice exhibit reduced 
disease severity and decreased inflammatory response in the brain in murine 
neurocysticercosis. J Immunol 169:3163-71. 
143. Shechter R, London A, Varol C, Raposo C, Cusimano M, Yovel G, Rolls A, 
Mack M, Pluchino S, Martino G. 2009. Infiltrating blood-derived macrophages 
are vital cells playing an anti-inflammatory role in recovery from spinal cord 
injury in mice. PLoS medicine 6:e1000113. 
144. Nikolakopoulou AM, Dutta R, Chen Z, Miller RH, Trapp BD. 2013. Activated 
microglia enhance neurogenesis via trypsinogen secretion. Proceedings of the 
National Academy of Sciences 110:8714-8719. 
 
127 
145. Ekdahl CT, Claasen J-H, Bonde S, Kokaia Z, Lindvall O. 2003. Inflammation is 
detrimental for neurogenesis in adult brain. Proceedings of the National Academy 
of Sciences 100:13632-13637. 
146. Koh TJ, DiPietro LA. 2011. Inflammation and wound healing: the role of the 
macrophage. Expert reviews in molecular medicine 13. 
147. Lu K-T, Sun C-L, Wo PY, Yen H-H, Tang T-H, Ng M-C, Huang M-L, Yang Y-
L. 2011. Hippocampal neurogenesis after traumatic brain injury is mediated by 
vascular endothelial growth factor receptor-2 and the Raf/MEK/ERK cascade. 
Journal of neurotrauma 28:441-450. 
148. Hu X, Li P, Guo Y, Wang H, Leak RK, Chen S, Gao Y, Chen J. 2012. 
Microglia/macrophage polarization dynamics reveal novel mechanism of injury 
expansion after focal cerebral ischemia. Stroke 43:3063-3070. 
149. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. 
2009. Identification of two distinct macrophage subsets with divergent effects 
causing either neurotoxicity or regeneration in the injured mouse spinal cord. 
Journal of Neuroscience 29:13435-13444. 
150. Perego C, Fumagalli S, De Simoni M-G. 2011. Temporal pattern of expression 
and colocalization of microglia/macrophage phenotype markers following brain 
ischemic injury in mice. Journal of neuroinflammation 8:174. 
151. Finkelman FD, Shea‐Donohue T, Morris SC, Gildea L, Strait R, Madden KB, 
Schopf L, Urban JF. 2004. Interleukin‐4‐and interleukin‐13‐mediated host 
protection against intestinal nematode parasites. Immunological reviews 201:139-
155. 
152. Gause WC, Urban JF, Stadecker MJ. 2003. The immune response to parasitic 
helminths: insights from murine models. Trends in immunology 24:269-277. 
153. Reyes J, Terrazas L. 2007. The divergent roles of alternatively activated 
macrophages in helminthic infections. Parasite immunology 29:609-619. 
154. Alvarez JI, Teale JM. 2006. Breakdown of the blood brain barrier and blood-
cerebrospinal fluid barrier is associated with differential leukocyte migration in 
distinct compartments of the CNS during the course of murine NCC. J 
Neuroimmunol 173:45-55. 
155. Cummings RD, Nyame AK. 1996. Glycobiology of schistosomiasis. FASEB J 
10:838-48. 
156. Khoo KH, Dell A. 2001. Glycoconjugates from parasitic helminths: structure 
diversity and immunobiological implications. Adv Exp Med Biol 491:185-205. 
157. Dell A, Haslam SM, Morris HR, Khoo KH. 1999. Immunogenic glycoconjugates 
implicated in parasitic nematode diseases. Biochimica Et Biophysica Acta 
1455:353-62. 
158. Sotelo J, Del Brutto OH. 2002. Review of neurocysticercosis. Neurosurg Focus 
12:e1. 
159. Garcia-Vallejo JJ, van Kooyk Y. 2009. Endogenous ligands for C-type lectin 
receptors: the true regulators of immune homeostasis. Immunol Rev 230:22-37. 
160. Sakaguchi M, Imaizumi Y, Okano H. 2007. Expression and function of galectin-1 
in adult neural stem cells. Cell Mol Life Sci 64:1254-8. 
161. Yan YP, Lang BT, Vemuganti R, Dempsey RJ. 2009. Galectin-3 mediates post-
ischemic tissue remodeling. Brain Res 1288:116-24. 
 
128 
162. Yamasaki S, Ishikawa E, Sakuma M, Hara H, Ogata K, Saito T. 2008. Mincle is 
an ITAM-coupled activating receptor that senses damaged cells. Nat Immunol 
9:1179-88. 
163. Nieminen J, St-Pierre C, Bhaumik P, Poirier F, Sato S. 2008. Role of galectin-3 in 
leukocyte recruitment in a murine model of lung infection by Streptococcus 
pneumoniae. J Immunol 180:2466-73. 
164. Fukumori T, Takenaka Y, Yoshii T, Kim HR, Hogan V, Inohara H, Kagawa S, 
Raz A. 2003. CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. 
Cancer Res 63:8302-11. 
165. Vasta GR, Ahmed H, Bianchet MA, Fernandez-Robledo JA, Amzel LM. 2012. 
Diversity in recognition of glycans by F-type lectins and galectins: molecular, 
structural, and biophysical aspects. Ann N Y Acad Sci 1253:E14-26. 
166. Faz-López B, Morales-Montor J, Terrazas LI. 2016. Role of macrophages in the 
repair process during the tissue migrating and resident helminth infections. 
BioMed research international 2016. 
167. Kreider T, Anthony RM, Urban JF, Jr., Gause WC. 2007. Alternatively activated 
macrophages in helminth infections. Curr Opin Immunol 19:448-53. 
168. Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A. 2012. Neutrophil 
function: from mechanisms to disease. Annual review of immunology 30:459-
489. 
169. Rőszer T. 2015. Understanding the mysterious M2 macrophage through activation 
markers and effector mechanisms. Mediators of inflammation 2015. 
170. Bhaumik P, St-Pierre G, Milot V, St-Pierre C, Sato S. 2013. Galectin-3 facilitates 
neutrophil recruitment as an innate immune response to a parasitic protozoa 
cutaneous infection. The Journal of Immunology 190:630-640. 
171. Bernardes ES, Silva NM, Ruas LP, Mineo JR, Loyola AM, Hsu DK, Liu F-T, 
Chammas R, Roque-Barreira MC. 2006. Toxoplasma gondii infection reveals a 
novel regulatory role for galectin-3 in the interface of innate and adaptive 
immunity. The American journal of pathology 168:1910-1920. 
172. Mares CA, Sharma J, Li Q, Rangel EL, Morris EG, Enriquez MI, Teale JM. 
Defect in efferocytosis leads to alternative activation of macrophages in 
Francisella infections. Immunol Cell Biol 89:167-72. 
173. Martin CJ, Peters KN, Behar SM. Macrophages clean up: efferocytosis and 
microbial control. Curr Opin Microbiol 17:17-23. 
174. Ravichandran KS. Beginnings of a good apoptotic meal: the find-me and eat-me 
signaling pathways. Immunity 35:445-55. 
175. Ravichandran KS, Lorenz U. 2007. Engulfment of apoptotic cells: signals for a 
good meal. Nat Rev Immunol 7:964-74. 
176. Poon IK, Lucas CD, Rossi AG, Ravichandran KS. Apoptotic cell clearance: basic 
biology and therapeutic potential. Nat Rev Immunol 14:166-80. 
177. Steichen AL, Simonson TJ, Salmon SL, Metzger DW, Mishra BB, Sharma J. 
2015. Alarmin function of galectin-9 in murine respiratory tularemia. PloS one 
10:e0123573. 
 
 
129 
 
